activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1507328	CHEMBL827224	Inhibition of MAP/microtubule affinity-regulating kinase 3 (cTak1)	B	CC(CN(C)C)Oc1ccc(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL425904	=	IC50	nM	1508.0	CHEMBL5600	Homo sapiens	IC50	nM	1508.0
	1507328	CHEMBL827224	Inhibition of MAP/microtubule affinity-regulating kinase 3 (cTak1)	B	CC(CN(C)C)Oc1ccc(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL425904	=	IC50	nM	1508.0	CHEMBL5600	Homo sapiens	IC50	nM	1508.0
	1507344	CHEMBL827224	Inhibition of MAP/microtubule affinity-regulating kinase 3 (cTak1)	B	CC1(COc2ccc(Cl)cc2NC(=O)Nc2cnc(C#N)cn2)COC1		CHEMBL192161	>	IC50	nM	10000.0	CHEMBL5600	Homo sapiens	IC50	nM	10000.0
	1608386	CHEMBL881956	Inhibitory concentration against Mitogen-activated protein kinase kinase kinase 7 (TAK1)	B	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	>	IC50	nM	10000.0	CHEMBL5600	Homo sapiens	IC50	uM	10.0
	1722879	CHEMBL860202	Inhibition of CTAK1	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	6700.0	CHEMBL5600	Homo sapiens	Ki	nM	6700.0
	1722902	CHEMBL860202	Inhibition of CTAK1	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	6700.0	CHEMBL5600	Homo sapiens	Ki	nM	6700.0
	1722919	CHEMBL860202	Inhibition of CTAK1	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	6700.0	CHEMBL5600	Homo sapiens	Ki	nM	6700.0
	1722978	CHEMBL860202	Inhibition of CTAK1	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	6700.0	CHEMBL5600	Homo sapiens	Ki	nM	6700.0
	1722996	CHEMBL860202	Inhibition of CTAK1	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	6700.0	CHEMBL5600	Homo sapiens	Ki	nM	6700.0
	1723117	CHEMBL860202	Inhibition of CTAK1	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	6700.0	CHEMBL5600	Homo sapiens	Ki	nM	6700.0
	1744487	CHEMBL867304	Inhibition of CTAK	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	6700.0	CHEMBL5600	Homo sapiens	Ki	uM	6.7
	1790358	CHEMBL856385	Percent residual activity, relative to control, of MARK3 at 1uM concentration of inhibitor in presence of 5uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	53.0	CHEMBL5600	Homo sapiens	Activity	%	53.0
	1790412	CHEMBL856385	Percent residual activity, relative to control, of MARK3 at 1uM concentration of inhibitor in presence of 5uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	40.0	CHEMBL5600	Homo sapiens	Activity	%	40.0
	1916294	CHEMBL894155	Inhibition of recombinant cTAK by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080	=	IC50	nM	3650.0	CHEMBL5600	Homo sapiens	IC50	uM	3.65
	1916347	CHEMBL894155	Inhibition of recombinant cTAK by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL5600	Homo sapiens	IC50	uM	10.0
	2051606	CHEMBL942747	Inhibition of CTAK1	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	6667.0	CHEMBL5600	Homo sapiens	Ki	uM	6.667
	2206867	CHEMBL990542	Inhibition of STK10	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	640.0	CHEMBL5600	Homo sapiens	Kd	nM	640.0
Not Active	2302193	CHEMBL950862	Inhibition of human MARK3 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	2470262	CHEMBL987181	Inhibition of MARK3 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5600	Homo sapiens	INH	%	10.0
	2486596	CHEMBL994202	Inhibition of CTAK1	B	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	>	Ki	nM	6670.0	CHEMBL5600	Homo sapiens	Ki	uM	6.67
	2596885	CHEMBL1017896	Inhibition of MARK3 assessed as enzyme activity relative to control	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Activity	%	26.0	CHEMBL5600	Homo sapiens	Activity	%	26.0
	2635916	CHEMBL1004128	Inhibition of MARK3 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	75.0	CHEMBL5600	Homo sapiens	Residual_activity	%	75.0
	2635984	CHEMBL1004128	Inhibition of MARK3 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	75.0	CHEMBL5600	Homo sapiens	Residual_activity	%	75.0
	2636052	CHEMBL1004128	Inhibition of MARK3 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	100.0	CHEMBL5600	Homo sapiens	Residual_activity	%	100.0
	2894276	CHEMBL1063802	Binding constant for full-length MARK3	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894277	CHEMBL1063802	Binding constant for full-length MARK3	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894278	CHEMBL1063802	Binding constant for full-length MARK3	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894279	CHEMBL1063802	Binding constant for full-length MARK3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894280	CHEMBL1063802	Binding constant for full-length MARK3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894281	CHEMBL1063802	Binding constant for full-length MARK3	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894282	CHEMBL1063802	Binding constant for full-length MARK3	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3400.0	CHEMBL5600	Homo sapiens	Kd	nM	3400.0
	2894283	CHEMBL1063802	Binding constant for full-length MARK3	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894284	CHEMBL1063802	Binding constant for full-length MARK3	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894285	CHEMBL1063802	Binding constant for full-length MARK3	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894286	CHEMBL1063802	Binding constant for full-length MARK3	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894287	CHEMBL1063802	Binding constant for full-length MARK3	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894288	CHEMBL1063802	Binding constant for full-length MARK3	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894289	CHEMBL1063802	Binding constant for full-length MARK3	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894290	CHEMBL1063802	Binding constant for full-length MARK3	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894291	CHEMBL1063802	Binding constant for full-length MARK3	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894292	CHEMBL1063802	Binding constant for full-length MARK3	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894293	CHEMBL1063802	Binding constant for full-length MARK3	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	4000.0	CHEMBL5600	Homo sapiens	Kd	nM	4000.0
	2894294	CHEMBL1063802	Binding constant for full-length MARK3	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894295	CHEMBL1063802	Binding constant for full-length MARK3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	600.0	CHEMBL5600	Homo sapiens	Kd	nM	600.0
	2894296	CHEMBL1063802	Binding constant for full-length MARK3	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894297	CHEMBL1063802	Binding constant for full-length MARK3	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894298	CHEMBL1063802	Binding constant for full-length MARK3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894299	CHEMBL1063802	Binding constant for full-length MARK3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894300	CHEMBL1063802	Binding constant for full-length MARK3	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894301	CHEMBL1063802	Binding constant for full-length MARK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	21.0	CHEMBL5600	Homo sapiens	Kd	nM	21.0
	2894302	CHEMBL1063802	Binding constant for full-length MARK3	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894303	CHEMBL1063802	Binding constant for full-length MARK3	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894304	CHEMBL1063802	Binding constant for full-length MARK3	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894305	CHEMBL1063802	Binding constant for full-length MARK3	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894306	CHEMBL1063802	Binding constant for full-length MARK3	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894307	CHEMBL1063802	Binding constant for full-length MARK3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894308	CHEMBL1063802	Binding constant for full-length MARK3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.0	CHEMBL5600	Homo sapiens	Kd	nM	3.0
	2894309	CHEMBL1063802	Binding constant for full-length MARK3	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1100.0	CHEMBL5600	Homo sapiens	Kd	nM	1100.0
	2894310	CHEMBL1063802	Binding constant for full-length MARK3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	410.0	CHEMBL5600	Homo sapiens	Kd	nM	410.0
	2894311	CHEMBL1063802	Binding constant for full-length MARK3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	2500.0	CHEMBL5600	Homo sapiens	Kd	nM	2500.0
	2894312	CHEMBL1063802	Binding constant for full-length MARK3	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	2894313	CHEMBL1063802	Binding constant for full-length MARK3	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
Antagonist	2906729	CHEMBL1062760	Percentage MARK3 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	12.0	CHEMBL5600	Homo sapiens	Activity	%	12.0
	2906730	CHEMBL1062760	Percentage MARK3 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
Antagonist	2906731	CHEMBL1062760	Percentage MARK3 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	6.0	CHEMBL5600	Homo sapiens	Activity	%	6.0
	2906732	CHEMBL1063757	Percentage MARK3 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	79.0	CHEMBL5600	Homo sapiens	Activity	%	79.0
Antagonist	2906733	CHEMBL1063757	Percentage MARK3 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	3.0	CHEMBL5600	Homo sapiens	Activity	%	3.0
	2906734	CHEMBL1063757	Percentage MARK3 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	83.0	CHEMBL5600	Homo sapiens	Activity	%	83.0
	2906735	CHEMBL1063757	Percentage MARK3 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	89.0	CHEMBL5600	Homo sapiens	Activity	%	89.0
	2906736	CHEMBL1063757	Percentage MARK3 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	77.0	CHEMBL5600	Homo sapiens	Activity	%	77.0
Antagonist	2906737	CHEMBL1063757	Percentage MARK3 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	12.0	CHEMBL5600	Homo sapiens	Activity	%	12.0
	2906738	CHEMBL1063757	Percentage MARK3 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	73.0	CHEMBL5600	Homo sapiens	Activity	%	73.0
	2906739	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	98.0	CHEMBL5600	Homo sapiens	Activity	%	98.0
	2906740	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	105.0	CHEMBL5600	Homo sapiens	Activity	%	105.0
	2906741	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	75.0	CHEMBL5600	Homo sapiens	Activity	%	75.0
Antagonist	2906742	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	8.0	CHEMBL5600	Homo sapiens	Activity	%	8.0
	2906743	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	82.0	CHEMBL5600	Homo sapiens	Activity	%	82.0
	2906744	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	90.0	CHEMBL5600	Homo sapiens	Activity	%	90.0
	2906745	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	79.0	CHEMBL5600	Homo sapiens	Activity	%	79.0
Antagonist	2906746	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	50.0	CHEMBL5600	Homo sapiens	Activity	%	50.0
	2906747	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	79.0	CHEMBL5600	Homo sapiens	Activity	%	79.0
	2906748	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	93.0	CHEMBL5600	Homo sapiens	Activity	%	93.0
Antagonist	2906749	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	29.0	CHEMBL5600	Homo sapiens	Activity	%	29.0
	2906750	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	74.0	CHEMBL5600	Homo sapiens	Activity	%	74.0
	2906751	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	76.0	CHEMBL5600	Homo sapiens	Activity	%	76.0
	2906752	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	69.0	CHEMBL5600	Homo sapiens	Activity	%	69.0
	2906753	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	64.0	CHEMBL5600	Homo sapiens	Activity	%	64.0
Antagonist	2906754	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	30.0	CHEMBL5600	Homo sapiens	Activity	%	30.0
	2906755	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	55.0	CHEMBL5600	Homo sapiens	Activity	%	55.0
	2906756	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	122.0	CHEMBL5600	Homo sapiens	Activity	%	122.0
	2906757	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	83.0	CHEMBL5600	Homo sapiens	Activity	%	83.0
	2906758	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	113.0	CHEMBL5600	Homo sapiens	Activity	%	113.0
	2906759	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	89.0	CHEMBL5600	Homo sapiens	Activity	%	89.0
	2906760	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	101.0	CHEMBL5600	Homo sapiens	Activity	%	101.0
	2906761	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	95.0	CHEMBL5600	Homo sapiens	Activity	%	95.0
	2906762	CHEMBL1060203	Percentage MARK3 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	95.0	CHEMBL5600	Homo sapiens	Activity	%	95.0
	2906763	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	63.0	CHEMBL5600	Homo sapiens	Activity	%	63.0
	2906764	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	91.0	CHEMBL5600	Homo sapiens	Activity	%	91.0
	2906765	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
Antagonist	2906766	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	36.0	CHEMBL5600	Homo sapiens	Activity	%	36.0
	2906767	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	74.0	CHEMBL5600	Homo sapiens	Activity	%	74.0
	2906768	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	70.0	CHEMBL5600	Homo sapiens	Activity	%	70.0
	2906769	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	80.0	CHEMBL5600	Homo sapiens	Activity	%	80.0
	2906770	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	98.0	CHEMBL5600	Homo sapiens	Activity	%	98.0
	2906771	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	66.0	CHEMBL5600	Homo sapiens	Activity	%	66.0
	2906772	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	85.0	CHEMBL5600	Homo sapiens	Activity	%	85.0
	2906773	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	87.0	CHEMBL5600	Homo sapiens	Activity	%	87.0
	2906774	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	63.0	CHEMBL5600	Homo sapiens	Activity	%	63.0
Antagonist	2906775	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	36.0	CHEMBL5600	Homo sapiens	Activity	%	36.0
	2906776	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	109.0	CHEMBL5600	Homo sapiens	Activity	%	109.0
Antagonist	2906777	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	49.0	CHEMBL5600	Homo sapiens	Activity	%	49.0
	2906778	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	86.0	CHEMBL5600	Homo sapiens	Activity	%	86.0
	2906779	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	83.0	CHEMBL5600	Homo sapiens	Activity	%	83.0
	2906780	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	131.0	CHEMBL5600	Homo sapiens	Activity	%	131.0
	2906781	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	128.0	CHEMBL5600	Homo sapiens	Activity	%	128.0
	2906782	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	110.0	CHEMBL5600	Homo sapiens	Activity	%	110.0
	2906783	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	92.0	CHEMBL5600	Homo sapiens	Activity	%	92.0
	2906784	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	74.0	CHEMBL5600	Homo sapiens	Activity	%	74.0
	2906785	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	66.0	CHEMBL5600	Homo sapiens	Activity	%	66.0
	2906786	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	54.0	CHEMBL5600	Homo sapiens	Activity	%	54.0
	2906787	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	67.0	CHEMBL5600	Homo sapiens	Activity	%	67.0
	2906788	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	126.0	CHEMBL5600	Homo sapiens	Activity	%	126.0
	2906789	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	72.0	CHEMBL5600	Homo sapiens	Activity	%	72.0
	2906790	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	88.0	CHEMBL5600	Homo sapiens	Activity	%	88.0
Antagonist	2906791	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	44.0	CHEMBL5600	Homo sapiens	Activity	%	44.0
Antagonist	2906792	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	25.0	CHEMBL5600	Homo sapiens	Activity	%	25.0
	2906793	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	92.0	CHEMBL5600	Homo sapiens	Activity	%	92.0
	2906794	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	84.0	CHEMBL5600	Homo sapiens	Activity	%	84.0
	2906795	CHEMBL1063734	Percentage MARK3 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	128.0	CHEMBL5600	Homo sapiens	Activity	%	128.0
	2906796	CHEMBL1060143	Percentage MARK3 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	88.0	CHEMBL5600	Homo sapiens	Activity	%	88.0
	2906797	CHEMBL1060143	Percentage MARK3 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	78.0	CHEMBL5600	Homo sapiens	Activity	%	78.0
	2906798	CHEMBL1052102	Percentage MARK3 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	76.0	CHEMBL5600	Homo sapiens	Activity	%	76.0
	2906799	CHEMBL1060144	Percentage MARK3 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	80.0	CHEMBL5600	Homo sapiens	Activity	%	80.0
	2921275	CHEMBL1047441	Inhibition of MARK3 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	2924833	CHEMBL1056881	Inhibition of MARK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	94.0	CHEMBL5600	Homo sapiens	Activity	%	94.0
	2924834	CHEMBL1056881	Inhibition of MARK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	116.0	CHEMBL5600	Homo sapiens	Activity	%	116.0
	2924835	CHEMBL1056881	Inhibition of MARK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	105.0	CHEMBL5600	Homo sapiens	Activity	%	105.0
	2924836	CHEMBL1056881	Inhibition of MARK3 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	88.0	CHEMBL5600	Homo sapiens	Activity	%	88.0
	2926226	CHEMBL1054466	Inhibition of MARK3 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	111.0	CHEMBL5600	Homo sapiens	Activity	%	111.0
	2928412	CHEMBL1055323	Inhibition of MARK3 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	96.0	CHEMBL5600	Homo sapiens	Activity	%	96.0
Not Active	2938618	CHEMBL1041488	Inhibition of c-TAK1 at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	2999022	CHEMBL1043725	Inhibition of MARK3 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	95.0	CHEMBL5600	Homo sapiens	Activity	%	95.0
	2999812	CHEMBL1043725	Inhibition of MARK3 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	92.0	CHEMBL5600	Homo sapiens	Activity	%	92.0
	2999885	CHEMBL1049887	Inhibition of MARK3 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	87.0	CHEMBL5600	Homo sapiens	Activity	%	87.0
	2999961	CHEMBL1049887	Inhibition of MARK3 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	89.0	CHEMBL5600	Homo sapiens	Activity	%	89.0
	3052654	CHEMBL1041141	Residual activity of MARK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	91.0	CHEMBL5600	Homo sapiens	Residual activity	%	91.0
	3053963	CHEMBL1050294	Residual activity of MARK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	104.0	CHEMBL5600	Homo sapiens	Residual activity	%	104.0
	3054215	CHEMBL1040683	Residual activity of MARK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	92.0	CHEMBL5600	Homo sapiens	Residual activity	%	92.0
	3055502	CHEMBL1041141	Residual activity of MARK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL5600	Homo sapiens	Residual activity	%	93.0
	3056807	CHEMBL1050294	Residual activity of MARK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	107.0	CHEMBL5600	Homo sapiens	Residual activity	%	107.0
	3057059	CHEMBL1040683	Residual activity of MARK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	84.0	CHEMBL5600	Homo sapiens	Residual activity	%	84.0
	3058379	CHEMBL1041141	Residual activity of MARK3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	91.0	CHEMBL5600	Homo sapiens	Residual activity	%	91.0
	3058631	CHEMBL1050294	Residual activity of MARK3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	108.0	CHEMBL5600	Homo sapiens	Residual activity	%	108.0
	3062483	CHEMBL1037970	Binding affinity to human MARK3 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	18.0	CHEMBL5600	Homo sapiens	Activity	%	18.0
	3063618	CHEMBL1074884	Binding affinity to human MARK3 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	16.0	CHEMBL5600	Homo sapiens	Activity	%	16.0
	3063708	CHEMBL1042470	Binding affinity to human MARK3 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	61.0	CHEMBL5600	Homo sapiens	Activity	%	61.0
	3066863	CHEMBL1066069	Inhibition of MARK3 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	3066953	CHEMBL1066069	Inhibition of MARK3 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	3072977	CHEMBL1040683	Residual activity of MARK3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL5600	Homo sapiens	Residual activity	%	87.0
	3084383	CHEMBL1072662	Inhibition of CTAK1	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	210.0	CHEMBL5600	Homo sapiens	IC50	uM	0.21
	3130801	CHEMBL1065092	Inhibition of MARK3 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3131763	CHEMBL1065767	Inhibition of MARK3 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3213962	CHEMBL1116710	Inhibition of MARK3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL5600	Homo sapiens	INH	%	4.0
	3224883	CHEMBL1100961	Inhibition of MARK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3226262	CHEMBL1100961	Inhibition of MARK3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3261350	CHEMBL1105206	Inhibition of MARK3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	94.0	CHEMBL5600	Homo sapiens	Activity	%	94.0
	3261444	CHEMBL1105206	Inhibition of MARK3 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	86.0	CHEMBL5600	Homo sapiens	Activity	%	86.0
Not Active	3271856	CHEMBL1112908	Inhibition of C-TAK1	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271857	CHEMBL1112908	Inhibition of C-TAK1	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271858	CHEMBL1112908	Inhibition of C-TAK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271859	CHEMBL1112908	Inhibition of C-TAK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271860	CHEMBL1112908	Inhibition of C-TAK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271861	CHEMBL1112908	Inhibition of C-TAK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271862	CHEMBL1112908	Inhibition of C-TAK1	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271863	CHEMBL1112908	Inhibition of C-TAK1	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271864	CHEMBL1112908	Inhibition of C-TAK1	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Not Active	3271865	CHEMBL1112908	Inhibition of C-TAK1	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	3271866	CHEMBL1112908	Inhibition of C-TAK1	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL5600	Homo sapiens	INH	%	20.0
Not Active	3271867	CHEMBL1112908	Inhibition of C-TAK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	3306922	CHEMBL1117948	Inhibition of MARK3 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	68.0	CHEMBL5600	Homo sapiens	INH	%	68.0
	3332018	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3333433	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3334838	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3336258	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3337578	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3338909	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3339162	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3340466	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3341800	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3343247	CHEMBL1166068	Inhibition of MARK3 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	3358659	CHEMBL1174901	Inhibition of MARK3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	69.0	CHEMBL5600	Homo sapiens	INH	%	69.0
	3359101	CHEMBL1174901	Inhibition of MARK3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	42.0	CHEMBL5600	Homo sapiens	INH	%	42.0
	3445190	CHEMBL1244502	Binding affinity to MARK3	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	49.0	CHEMBL5600	Homo sapiens	Kd	nM	49.0
	3448494	CHEMBL1244502	Binding affinity to MARK3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	3448982	CHEMBL1244502	Binding affinity to MARK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	21.0	CHEMBL5600	Homo sapiens	Kd	nM	21.0
	3449265	CHEMBL1244502	Binding affinity to MARK3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	410.0	CHEMBL5600	Homo sapiens	Kd	nM	410.0
	3449266	CHEMBL1244502	Binding affinity to MARK3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	490.0	CHEMBL5600	Homo sapiens	Kd	nM	490.0
	3449727	CHEMBL1244502	Binding affinity to MARK3	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	3450131	CHEMBL1244502	Binding affinity to MARK3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	uM	10.0
	5191405	CHEMBL1664059	Inhibition of MARK3 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	93.0	CHEMBL5600	Homo sapiens	INH	%	93.0
	5191406	CHEMBL1664059	Inhibition of MARK3 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	96.0	CHEMBL5600	Homo sapiens	INH	%	96.0
	6273838	CHEMBL1806160	Inhibition of MARK3 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	82.0	CHEMBL5600	Homo sapiens	Activity	%	82.0
	6341086	CHEMBL1828399	Activity of MARK3 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	6352234	CHEMBL1825841	Inhibition of MARK3 assessed as residual activity at 10 uM by radioactivity assay in presence of 5 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	50.0	CHEMBL5600	Homo sapiens	Activity	%	50.0
	6385548	CHEMBL1837943	Inhibition of human MARK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL5600	Homo sapiens	INH	%	35.0
	6385549	CHEMBL1837943	Inhibition of human MARK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL5600	Homo sapiens	INH	%	35.0
	6385550	CHEMBL1837943	Inhibition of human MARK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL5600	Homo sapiens	INH	%	35.0
	6385551	CHEMBL1837943	Inhibition of human MARK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL5600	Homo sapiens	INH	%	35.0
	6385552	CHEMBL1837943	Inhibition of human MARK3 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL5600	Homo sapiens	INH	%	35.0
	7567258	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7567717	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7568188	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7568646	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1100.0	CHEMBL5600	Homo sapiens	Kd	nM	1100.0
	7569231	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7569691	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7570184	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7570611	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	410.0	CHEMBL5600	Homo sapiens	Kd	nM	410.0
	7571207	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7571664	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7571698	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7572161	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7572577	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	12.0	CHEMBL5600	Homo sapiens	Kd	nM	12.0
	7573188	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	770.0	CHEMBL5600	Homo sapiens	Kd	nM	770.0
	7573679	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	6200.0	CHEMBL5600	Homo sapiens	Kd	nM	6200.0
	7574148	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	21.0	CHEMBL5600	Homo sapiens	Kd	nM	21.0
	7574556	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7575185	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7575656	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7576121	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7576529	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	300.0	CHEMBL5600	Homo sapiens	Kd	nM	300.0
	7576698	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7577157	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7577635	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1300.0	CHEMBL5600	Homo sapiens	Kd	nM	1300.0
	7578105	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7578510	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7578706	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7579080	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7579530	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7580004	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7580473	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7580876	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	2500.0	CHEMBL5600	Homo sapiens	Kd	nM	2500.0
	7581064	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7581449	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7581894	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7582365	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7583410	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7583807	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7584252	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7584723	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7584743	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1900.0	CHEMBL5600	Homo sapiens	Kd	nM	1900.0
	7585147	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7585740	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7586148	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7586594	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7587077	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7587701	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7588120	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	49.0	CHEMBL5600	Homo sapiens	Kd	nM	49.0
	7588602	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7589053	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7589666	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7590090	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3400.0	CHEMBL5600	Homo sapiens	Kd	nM	3400.0
	7590115	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7590589	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7591040	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7592091	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7592564	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7593017	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7593164	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7593599	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7594071	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7594544	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7594996	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7595132	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7595576	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7596050	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7596521	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	4000.0	CHEMBL5600	Homo sapiens	Kd	nM	4000.0
	7596968	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.0	CHEMBL5600	Homo sapiens	Kd	nM	3.0
	7597104	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7597557	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7598030	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5600	Homo sapiens	Kd	nM	10000.0
	7598500	CHEMBL1908560	Binding constant for MARK3 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	740.0	CHEMBL5600	Homo sapiens	Kd	nM	740.0
	7969747	CHEMBL1931446	Inhibition of MARK3 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	81.0	CHEMBL5600	Homo sapiens	Activity	%	81.0
	7970422	CHEMBL1930195	Inhibition of c-TAK1 at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	6.0	CHEMBL5600	Homo sapiens	INH	%	6.0
	8061268	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.33	CHEMBL5600	Homo sapiens	Inhibition	%	0.33
	8061445	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	4.6	CHEMBL5600	Homo sapiens	Inhibition	%	4.6
	8061776	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.89	CHEMBL5600	Homo sapiens	Inhibition	%	2.89
	8061967	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.73	CHEMBL5600	Homo sapiens	Inhibition	%	4.73
	8062191	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	7.16	CHEMBL5600	Homo sapiens	Inhibition	%	7.16
	8062307	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.25	CHEMBL5600	Homo sapiens	Inhibition	%	0.25
	8062693	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.28	CHEMBL5600	Homo sapiens	Inhibition	%	3.28
	8062791	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.4	CHEMBL5600	Homo sapiens	Inhibition	%	1.4
	8063015	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.16	CHEMBL5600	Homo sapiens	Inhibition	%	2.16
	8063147	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	5.09	CHEMBL5600	Homo sapiens	Inhibition	%	5.09
	8063314	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.96	CHEMBL5600	Homo sapiens	Inhibition	%	-0.96
	8063538	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	6.57	CHEMBL5600	Homo sapiens	Inhibition	%	6.57
	8063646	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.26	CHEMBL5600	Homo sapiens	Inhibition	%	2.26
	8064052	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.14	CHEMBL5600	Homo sapiens	Inhibition	%	2.14
	8064167	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	9.08	CHEMBL5600	Homo sapiens	Inhibition	%	9.08
	8064391	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.76	CHEMBL5600	Homo sapiens	Inhibition	%	2.76
	8064601	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.12	CHEMBL5600	Homo sapiens	Inhibition	%	-0.12
	8064739	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.59	CHEMBL5600	Homo sapiens	Inhibition	%	4.59
	8065129	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.03	CHEMBL5600	Homo sapiens	Inhibition	%	2.03
	8065245	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	10.99	CHEMBL5600	Homo sapiens	Inhibition	%	10.99
	8065469	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.56	CHEMBL5600	Homo sapiens	Inhibition	%	3.56
	8065644	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.45	CHEMBL5600	Homo sapiens	Inhibition	%	3.45
	8065983	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	12.21	CHEMBL5600	Homo sapiens	Inhibition	%	12.21
	8066193	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.0	CHEMBL5600	Homo sapiens	Inhibition	%	1.0
	8066329	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	26.69	CHEMBL5600	Homo sapiens	Inhibition	%	26.69
	8066553	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.88	CHEMBL5600	Homo sapiens	Inhibition	%	6.88
	8066719	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.41	CHEMBL5600	Homo sapiens	Inhibition	%	2.41
	8067067	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.7	CHEMBL5600	Homo sapiens	Inhibition	%	1.7
	8067242	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.97	CHEMBL5600	Homo sapiens	Inhibition	%	3.97
	8067587	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.0	CHEMBL5600	Homo sapiens	Inhibition	%	1.0
	8067797	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.48	CHEMBL5600	Homo sapiens	Inhibition	%	-0.48
	8068156	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	34.08	CHEMBL5600	Homo sapiens	Inhibition	%	34.08
	8068320	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.93	CHEMBL5600	Homo sapiens	Inhibition	%	-0.93
	8068669	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.62	CHEMBL5600	Homo sapiens	Inhibition	%	-0.62
	8068843	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.83	CHEMBL5600	Homo sapiens	Inhibition	%	0.83
	8069192	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.24	CHEMBL5600	Homo sapiens	Inhibition	%	-0.24
	8069487	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.0	CHEMBL5600	Homo sapiens	Inhibition	%	6.0
	8069648	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	7.34	CHEMBL5600	Homo sapiens	Inhibition	%	7.34
	8069872	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.64	CHEMBL5600	Homo sapiens	Inhibition	%	3.64
	8069998	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.66	CHEMBL5600	Homo sapiens	Inhibition	%	1.66
	8070170	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.34	CHEMBL5600	Homo sapiens	Inhibition	%	2.34
	8070394	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.76	CHEMBL5600	Homo sapiens	Inhibition	%	0.76
	8070519	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-3.53	CHEMBL5600	Homo sapiens	Inhibition	%	-3.53
	8070817	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	45.99	CHEMBL5600	Homo sapiens	Inhibition	%	45.99
	8071198	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.21	CHEMBL5600	Homo sapiens	Inhibition	%	1.21
	8071324	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.37	CHEMBL5600	Homo sapiens	Inhibition	%	-0.37
	8071721	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.8	CHEMBL5600	Homo sapiens	Inhibition	%	4.8
	8071846	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.71	CHEMBL5600	Homo sapiens	Inhibition	%	0.71
	8072070	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.41	CHEMBL5600	Homo sapiens	Inhibition	%	0.41
	8072160	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.8	CHEMBL5600	Homo sapiens	Inhibition	%	0.8
	8072384	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.94	CHEMBL5600	Homo sapiens	Inhibition	%	1.94
	8072541	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.57	CHEMBL5600	Homo sapiens	Inhibition	%	1.57
	8072666	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.24	CHEMBL5600	Homo sapiens	Inhibition	%	0.24
	8072890	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.15	CHEMBL5600	Homo sapiens	Inhibition	%	0.15
	8073057	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-5.02	CHEMBL5600	Homo sapiens	Inhibition	%	-5.02
	8073406	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.18	CHEMBL5600	Homo sapiens	Inhibition	%	-0.18
	8073525	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.22	CHEMBL5600	Homo sapiens	Inhibition	%	-0.22
	8073749	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.82	CHEMBL5600	Homo sapiens	Inhibition	%	3.82
	8073982	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	4.42	CHEMBL5600	Homo sapiens	Inhibition	%	4.42
	8074134	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.58	CHEMBL5600	Homo sapiens	Inhibition	%	2.58
	8074488	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	3.36	CHEMBL5600	Homo sapiens	Inhibition	%	3.36
	8074645	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	9.03	CHEMBL5600	Homo sapiens	Inhibition	%	9.03
	8074996	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.2	CHEMBL5600	Homo sapiens	Inhibition	%	0.2
	8075331	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.21	CHEMBL5600	Homo sapiens	Inhibition	%	2.21
	8075568	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	15.37	CHEMBL5600	Homo sapiens	Inhibition	%	15.37
	8075709	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.32	CHEMBL5600	Homo sapiens	Inhibition	%	3.32
	8075933	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.0	CHEMBL5600	Homo sapiens	Inhibition	%	8.0
	8076075	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.92	CHEMBL5600	Homo sapiens	Inhibition	%	-0.92
	8076223	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.15	CHEMBL5600	Homo sapiens	Inhibition	%	5.15
	8076447	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.88	CHEMBL5600	Homo sapiens	Inhibition	%	3.88
	8076581	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.2	CHEMBL5600	Homo sapiens	Inhibition	%	3.2
	8076907	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	21.98	CHEMBL5600	Homo sapiens	Inhibition	%	21.98
	8077154	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	83.32	CHEMBL5600	Homo sapiens	Inhibition	%	83.32
	8077506	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.09	CHEMBL5600	Homo sapiens	Inhibition	%	2.09
	8077657	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.97	CHEMBL5600	Homo sapiens	Inhibition	%	1.97
	8078024	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.74	CHEMBL5600	Homo sapiens	Inhibition	%	1.74
	8078163	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.26	CHEMBL5600	Homo sapiens	Inhibition	%	0.26
	8078489	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.82	CHEMBL5600	Homo sapiens	Inhibition	%	0.82
	8078739	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	101.34	CHEMBL5600	Homo sapiens	Inhibition	%	101.34
	8079079	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.82	CHEMBL5600	Homo sapiens	Inhibition	%	4.82
	8079237	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.4	CHEMBL5600	Homo sapiens	Inhibition	%	0.4
	8079461	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	5.81	CHEMBL5600	Homo sapiens	Inhibition	%	5.81
	8079603	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.88	CHEMBL5600	Homo sapiens	Inhibition	%	2.88
	8079742	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	4.97	CHEMBL5600	Homo sapiens	Inhibition	%	4.97
	8079966	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	12.21	CHEMBL5600	Homo sapiens	Inhibition	%	12.21
	8080071	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	3.01	CHEMBL5600	Homo sapiens	Inhibition	%	3.01
	8080323	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	33.33	CHEMBL5600	Homo sapiens	Inhibition	%	33.33
	8080547	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	88.65	CHEMBL5600	Homo sapiens	Inhibition	%	88.65
	8080662	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.64	CHEMBL5600	Homo sapiens	Inhibition	%	1.64
	8081050	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.05	CHEMBL5600	Homo sapiens	Inhibition	%	-0.05
	8081185	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.39	CHEMBL5600	Homo sapiens	Inhibition	%	1.39
	8081553	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	66.64	CHEMBL5600	Homo sapiens	Inhibition	%	66.64
	8081656	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	5.22	CHEMBL5600	Homo sapiens	Inhibition	%	5.22
	8081880	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	18.56	CHEMBL5600	Homo sapiens	Inhibition	%	18.56
	8082132	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.04	CHEMBL5600	Homo sapiens	Inhibition	%	4.04
	8082245	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.15	CHEMBL5600	Homo sapiens	Inhibition	%	3.15
	8082642	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.65	CHEMBL5600	Homo sapiens	Inhibition	%	0.65
	8082765	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.09	CHEMBL5600	Homo sapiens	Inhibition	%	3.09
	8082989	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.6	CHEMBL5600	Homo sapiens	Inhibition	%	0.6
	8083145	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.88	CHEMBL5600	Homo sapiens	Inhibition	%	1.88
	8083468	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.49	CHEMBL5600	Homo sapiens	Inhibition	%	1.49
	8083722	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	24.22	CHEMBL5600	Homo sapiens	Inhibition	%	24.22
	8083832	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.93	CHEMBL5600	Homo sapiens	Inhibition	%	0.93
	8084056	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	6.18	CHEMBL5600	Homo sapiens	Inhibition	%	6.18
	8084241	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.25	CHEMBL5600	Homo sapiens	Inhibition	%	8.25
	8084583	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.52	CHEMBL5600	Homo sapiens	Inhibition	%	0.52
	8084744	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.47	CHEMBL5600	Homo sapiens	Inhibition	%	5.47
	8085066	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	6.61	CHEMBL5600	Homo sapiens	Inhibition	%	6.61
	8085322	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.53	CHEMBL5600	Homo sapiens	Inhibition	%	0.53
	8085654	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.17	CHEMBL5600	Homo sapiens	Inhibition	%	3.17
	8085843	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	40.9	CHEMBL5600	Homo sapiens	Inhibition	%	40.9
	8086182	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-0.35	CHEMBL5600	Homo sapiens	Inhibition	%	-0.35
	8086344	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.22	CHEMBL5600	Homo sapiens	Inhibition	%	-0.22
	8086568	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.99	CHEMBL5600	Homo sapiens	Inhibition	%	2.99
	8086667	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.13	CHEMBL5600	Homo sapiens	Inhibition	%	0.13
	8086878	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.82	CHEMBL5600	Homo sapiens	Inhibition	%	1.82
	8087102	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.1	CHEMBL5600	Homo sapiens	Inhibition	%	3.1
	8087260	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.99	CHEMBL5600	Homo sapiens	Inhibition	%	-0.99
	8087598	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.5	CHEMBL5600	Homo sapiens	Inhibition	%	4.5
	8087736	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.84	CHEMBL5600	Homo sapiens	Inhibition	%	2.84
	8088102	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.99	CHEMBL5600	Homo sapiens	Inhibition	%	7.99
	8088250	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.54	CHEMBL5600	Homo sapiens	Inhibition	%	-0.54
	8088474	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.12	CHEMBL5600	Homo sapiens	Inhibition	%	0.12
	8088602	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.06	CHEMBL5600	Homo sapiens	Inhibition	%	4.06
	8088919	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	22.25	CHEMBL5600	Homo sapiens	Inhibition	%	22.25
	8089047	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.83	CHEMBL5600	Homo sapiens	Inhibition	%	-0.83
	8089271	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.93	CHEMBL5600	Homo sapiens	Inhibition	%	1.93
	8089419	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.08	CHEMBL5600	Homo sapiens	Inhibition	%	2.08
	8089763	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.45	CHEMBL5600	Homo sapiens	Inhibition	%	1.45
	8089943	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.99	CHEMBL5600	Homo sapiens	Inhibition	%	-0.99
	8090332	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.29	CHEMBL5600	Homo sapiens	Inhibition	%	3.29
	8090499	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.93	CHEMBL5600	Homo sapiens	Inhibition	%	0.93
	8090862	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.62	CHEMBL5600	Homo sapiens	Inhibition	%	1.62
	8091067	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.62	CHEMBL5600	Homo sapiens	Inhibition	%	0.62
	8091428	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.37	CHEMBL5600	Homo sapiens	Inhibition	%	2.37
	8091583	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-1.15	CHEMBL5600	Homo sapiens	Inhibition	%	-1.15
	8091923	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.87	CHEMBL5600	Homo sapiens	Inhibition	%	4.87
	8092060	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.57	CHEMBL5600	Homo sapiens	Inhibition	%	0.57
	8092284	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.46	CHEMBL5600	Homo sapiens	Inhibition	%	-0.46
	8092435	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.84	CHEMBL5600	Homo sapiens	Inhibition	%	0.84
	8092807	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.02	CHEMBL5600	Homo sapiens	Inhibition	%	0.02
	8092936	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	8.06	CHEMBL5600	Homo sapiens	Inhibition	%	8.06
	8093248	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.94	CHEMBL5600	Homo sapiens	Inhibition	%	0.94
	8093612	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.1	CHEMBL5600	Homo sapiens	Inhibition	%	3.1
	8093751	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	20.56	CHEMBL5600	Homo sapiens	Inhibition	%	20.56
	8094095	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-1.14	CHEMBL5600	Homo sapiens	Inhibition	%	-1.14
	8094275	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.4	CHEMBL5600	Homo sapiens	Inhibition	%	-0.4
	8094499	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.64	CHEMBL5600	Homo sapiens	Inhibition	%	1.64
	8094674	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	12.26	CHEMBL5600	Homo sapiens	Inhibition	%	12.26
	8094830	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.15	CHEMBL5600	Homo sapiens	Inhibition	%	4.15
	8095054	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.54	CHEMBL5600	Homo sapiens	Inhibition	%	1.54
	8095194	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.68	CHEMBL5600	Homo sapiens	Inhibition	%	-0.68
	8095397	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-0.22	CHEMBL5600	Homo sapiens	Inhibition	%	-0.22
	8095762	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	20.76	CHEMBL5600	Homo sapiens	Inhibition	%	20.76
	8095910	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.1	CHEMBL5600	Homo sapiens	Inhibition	%	0.1
	8096134	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.6	CHEMBL5600	Homo sapiens	Inhibition	%	2.6
	8096251	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.1	CHEMBL5600	Homo sapiens	Inhibition	%	3.1
	8096614	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.92	CHEMBL5600	Homo sapiens	Inhibition	%	-0.92
	8096770	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.64	CHEMBL5600	Homo sapiens	Inhibition	%	3.64
	8097141	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.4	CHEMBL5600	Homo sapiens	Inhibition	%	3.4
	8097448	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.84	CHEMBL5600	Homo sapiens	Inhibition	%	3.84
	8097672	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.06	CHEMBL5600	Homo sapiens	Inhibition	%	6.06
	8097822	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	28.12	CHEMBL5600	Homo sapiens	Inhibition	%	28.12
	8097955	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.09	CHEMBL5600	Homo sapiens	Inhibition	%	1.09
	8098179	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.98	CHEMBL5600	Homo sapiens	Inhibition	%	3.98
	8098299	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.28	CHEMBL5600	Homo sapiens	Inhibition	%	2.28
	8098703	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.1	CHEMBL5600	Homo sapiens	Inhibition	%	0.1
	8098888	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	67.38	CHEMBL5600	Homo sapiens	Inhibition	%	67.38
	8099256	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.7	CHEMBL5600	Homo sapiens	Inhibition	%	3.7
	8099398	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.67	CHEMBL5600	Homo sapiens	Inhibition	%	0.67
	8099592	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.94	CHEMBL5600	Homo sapiens	Inhibition	%	2.94
	8099816	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.43	CHEMBL5600	Homo sapiens	Inhibition	%	0.43
	8099963	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.69	CHEMBL5600	Homo sapiens	Inhibition	%	2.69
	8100333	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.61	CHEMBL5600	Homo sapiens	Inhibition	%	2.61
	8100449	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.6	CHEMBL5600	Homo sapiens	Inhibition	%	4.6
	8100673	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.6	CHEMBL5600	Homo sapiens	Inhibition	%	1.6
	8100813	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.17	CHEMBL5600	Homo sapiens	Inhibition	%	2.17
	8100973	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.29	CHEMBL5600	Homo sapiens	Inhibition	%	3.29
	8101197	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.66	CHEMBL5600	Homo sapiens	Inhibition	%	5.66
	8101339	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	2.51	CHEMBL5600	Homo sapiens	Inhibition	%	2.51
	8101524	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.81	CHEMBL5600	Homo sapiens	Inhibition	%	3.81
	8101748	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.11	CHEMBL5600	Homo sapiens	Inhibition	%	3.11
	8102001	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	11.84	CHEMBL5600	Homo sapiens	Inhibition	%	11.84
	8102156	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	2.03	CHEMBL5600	Homo sapiens	Inhibition	%	2.03
	8102511	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.45	CHEMBL5600	Homo sapiens	Inhibition	%	-0.45
	8102631	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.02	CHEMBL5600	Homo sapiens	Inhibition	%	2.02
	8102855	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.29	CHEMBL5600	Homo sapiens	Inhibition	%	1.29
	8103033	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.2	CHEMBL5600	Homo sapiens	Inhibition	%	3.2
	8103229	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.68	CHEMBL5600	Homo sapiens	Inhibition	%	4.68
	8103591	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.98	CHEMBL5600	Homo sapiens	Inhibition	%	1.98
	8103741	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.71	CHEMBL5600	Homo sapiens	Inhibition	%	3.71
	8103965	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.78	CHEMBL5600	Homo sapiens	Inhibition	%	0.78
	8104150	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.27	CHEMBL5600	Homo sapiens	Inhibition	%	0.27
	8104298	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.9	CHEMBL5600	Homo sapiens	Inhibition	%	6.9
	8104522	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.91	CHEMBL5600	Homo sapiens	Inhibition	%	4.91
	8104668	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	17.4	CHEMBL5600	Homo sapiens	Inhibition	%	17.4
	8105006	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.33	CHEMBL5600	Homo sapiens	Inhibition	%	0.33
	8105146	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.86	CHEMBL5600	Homo sapiens	Inhibition	%	0.86
	8105536	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.33	CHEMBL5600	Homo sapiens	Inhibition	%	4.33
	8105674	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	22.12	CHEMBL5600	Homo sapiens	Inhibition	%	22.12
	8105898	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.35	CHEMBL5600	Homo sapiens	Inhibition	%	3.35
	8105954	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.81	CHEMBL5600	Homo sapiens	Inhibition	%	3.81
	8106343	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.54	CHEMBL5600	Homo sapiens	Inhibition	%	3.54
	8106499	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	11.87	CHEMBL5600	Homo sapiens	Inhibition	%	11.87
	8106723	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	6.58	CHEMBL5600	Homo sapiens	Inhibition	%	6.58
	8106852	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	18.71	CHEMBL5600	Homo sapiens	Inhibition	%	18.71
	8107197	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.97	CHEMBL5600	Homo sapiens	Inhibition	%	2.97
	8107369	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.11	CHEMBL5600	Homo sapiens	Inhibition	%	1.11
	8107570	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	35.37	CHEMBL5600	Homo sapiens	Inhibition	%	35.37
	8107794	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.98	CHEMBL5600	Homo sapiens	Inhibition	%	3.98
	8107929	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.35	CHEMBL5600	Homo sapiens	Inhibition	%	2.35
	8108311	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.64	CHEMBL5600	Homo sapiens	Inhibition	%	3.64
	8108486	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.32	CHEMBL5600	Homo sapiens	Inhibition	%	-0.32
	8108857	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	31.16	CHEMBL5600	Homo sapiens	Inhibition	%	31.16
	8108999	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.76	CHEMBL5600	Homo sapiens	Inhibition	%	0.76
	8109337	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.26	CHEMBL5600	Homo sapiens	Inhibition	%	4.26
	8109467	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.77	CHEMBL5600	Homo sapiens	Inhibition	%	-0.77
	8109691	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.53	CHEMBL5600	Homo sapiens	Inhibition	%	-0.53
	8109862	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	8.01	CHEMBL5600	Homo sapiens	Inhibition	%	8.01
	8110218	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.48	CHEMBL5600	Homo sapiens	Inhibition	%	2.48
	8110273	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.64	CHEMBL5600	Homo sapiens	Inhibition	%	4.64
	8110497	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.7	CHEMBL5600	Homo sapiens	Inhibition	%	3.7
	8110663	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.0	CHEMBL5600	Homo sapiens	Inhibition	%	3.0
	8111045	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	11.42	CHEMBL5600	Homo sapiens	Inhibition	%	11.42
	8111168	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.5	CHEMBL5600	Homo sapiens	Inhibition	%	1.5
	8111519	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	14.9	CHEMBL5600	Homo sapiens	Inhibition	%	14.9
	8111685	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.82	CHEMBL5600	Homo sapiens	Inhibition	%	0.82
	8111909	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	5.88	CHEMBL5600	Homo sapiens	Inhibition	%	5.88
	8112114	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	9.41	CHEMBL5600	Homo sapiens	Inhibition	%	9.41
	8112251	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.48	CHEMBL5600	Homo sapiens	Inhibition	%	-0.48
	8112643	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-0.65	CHEMBL5600	Homo sapiens	Inhibition	%	-0.65
	8112815	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.66	CHEMBL5600	Homo sapiens	Inhibition	%	-2.66
	8113191	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.62	CHEMBL5600	Homo sapiens	Inhibition	%	0.62
	8113327	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.33	CHEMBL5600	Homo sapiens	Inhibition	%	1.33
	8113551	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.63	CHEMBL5600	Homo sapiens	Inhibition	%	0.63
	8113675	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.13	CHEMBL5600	Homo sapiens	Inhibition	%	5.13
	8114015	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.22	CHEMBL5600	Homo sapiens	Inhibition	%	-0.22
	8114191	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.32	CHEMBL5600	Homo sapiens	Inhibition	%	0.32
	8114547	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.1	CHEMBL5600	Homo sapiens	Inhibition	%	3.1
	8114823	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.82	CHEMBL5600	Homo sapiens	Inhibition	%	2.82
	8114989	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.57	CHEMBL5600	Homo sapiens	Inhibition	%	1.57
	8115378	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.78	CHEMBL5600	Homo sapiens	Inhibition	%	0.78
	8115498	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.47	CHEMBL5600	Homo sapiens	Inhibition	%	3.47
	8115722	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.69	CHEMBL5600	Homo sapiens	Inhibition	%	1.69
	8115855	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	67.86	CHEMBL5600	Homo sapiens	Inhibition	%	67.86
	8116238	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	36.61	CHEMBL5600	Homo sapiens	Inhibition	%	36.61
	8116441	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	21.18	CHEMBL5600	Homo sapiens	Inhibition	%	21.18
	8116575	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.26	CHEMBL5600	Homo sapiens	Inhibition	%	0.26
	8116799	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-3.67	CHEMBL5600	Homo sapiens	Inhibition	%	-3.67
	8116971	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.19	CHEMBL5600	Homo sapiens	Inhibition	%	5.19
	8117142	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-1.52	CHEMBL5600	Homo sapiens	Inhibition	%	-1.52
	8117366	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.2	CHEMBL5600	Homo sapiens	Inhibition	%	1.2
	8117524	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	11.63	CHEMBL5600	Homo sapiens	Inhibition	%	11.63
	8117878	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.81	CHEMBL5600	Homo sapiens	Inhibition	%	1.81
	8118016	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.47	CHEMBL5600	Homo sapiens	Inhibition	%	3.47
	8118356	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-0.24	CHEMBL5600	Homo sapiens	Inhibition	%	-0.24
	8118528	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.96	CHEMBL5600	Homo sapiens	Inhibition	%	3.96
	8118752	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.73	CHEMBL5600	Homo sapiens	Inhibition	%	2.73
	8118888	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.54	CHEMBL5600	Homo sapiens	Inhibition	%	4.54
	8119159	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.27	CHEMBL5600	Homo sapiens	Inhibition	%	-0.27
	8119318	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.97	CHEMBL5600	Homo sapiens	Inhibition	%	2.97
	8119542	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.21	CHEMBL5600	Homo sapiens	Inhibition	%	3.21
	8119709	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.05	CHEMBL5600	Homo sapiens	Inhibition	%	3.05
	8120052	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-1.39	CHEMBL5600	Homo sapiens	Inhibition	%	-1.39
	8120191	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.05	CHEMBL5600	Homo sapiens	Inhibition	%	-1.05
	8120575	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.73	CHEMBL5600	Homo sapiens	Inhibition	%	-1.73
	8120776	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	77.68	CHEMBL5600	Homo sapiens	Inhibition	%	77.68
	8121128	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-2.09	CHEMBL5600	Homo sapiens	Inhibition	%	-2.09
	8121300	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.46	CHEMBL5600	Homo sapiens	Inhibition	%	2.46
	8121691	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.11	CHEMBL5600	Homo sapiens	Inhibition	%	3.11
	8121854	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	-0.1	CHEMBL5600	Homo sapiens	Inhibition	%	-0.1
	8122199	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.4	CHEMBL5600	Homo sapiens	Inhibition	%	-1.4
	8122337	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	12.18	CHEMBL5600	Homo sapiens	Inhibition	%	12.18
	8122561	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	8.01	CHEMBL5600	Homo sapiens	Inhibition	%	8.01
	8122681	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.07	CHEMBL5600	Homo sapiens	Inhibition	%	2.07
	8123072	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.96	CHEMBL5600	Homo sapiens	Inhibition	%	2.96
	8123214	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.55	CHEMBL5600	Homo sapiens	Inhibition	%	5.55
	8123492	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.73	CHEMBL5600	Homo sapiens	Inhibition	%	0.73
	8123866	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	18.25	CHEMBL5600	Homo sapiens	Inhibition	%	18.25
	8124033	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.08	CHEMBL5600	Homo sapiens	Inhibition	%	1.08
	8124376	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.03	CHEMBL5600	Homo sapiens	Inhibition	%	4.03
	8124515	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	5.36	CHEMBL5600	Homo sapiens	Inhibition	%	5.36
	8124739	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.59	CHEMBL5600	Homo sapiens	Inhibition	%	-0.59
	8124904	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.28	CHEMBL5600	Homo sapiens	Inhibition	%	2.28
	8125105	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.13	CHEMBL5600	Homo sapiens	Inhibition	%	3.13
	8125329	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.86	CHEMBL5600	Homo sapiens	Inhibition	%	7.86
	8125459	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.23	CHEMBL5600	Homo sapiens	Inhibition	%	0.23
	8125627	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.78	CHEMBL5600	Homo sapiens	Inhibition	%	2.78
	8125851	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.46	CHEMBL5600	Homo sapiens	Inhibition	%	0.46
	8126015	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.37	CHEMBL5600	Homo sapiens	Inhibition	%	-0.37
	8126179	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.83	CHEMBL5600	Homo sapiens	Inhibition	%	5.83
	8126403	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.34	CHEMBL5600	Homo sapiens	Inhibition	%	4.34
	8126518	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.26	CHEMBL5600	Homo sapiens	Inhibition	%	-0.26
	8126878	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	42.94	CHEMBL5600	Homo sapiens	Inhibition	%	42.94
	8127000	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.76	CHEMBL5600	Homo sapiens	Inhibition	%	2.76
	8127224	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.05	CHEMBL5600	Homo sapiens	Inhibition	%	2.05
	8127391	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.77	CHEMBL5600	Homo sapiens	Inhibition	%	3.77
	8127533	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	21.53	CHEMBL5600	Homo sapiens	Inhibition	%	21.53
	8127757	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.75	CHEMBL5600	Homo sapiens	Inhibition	%	3.75
	8127821	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.73	CHEMBL5600	Homo sapiens	Inhibition	%	3.73
	8128045	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	29.33	CHEMBL5600	Homo sapiens	Inhibition	%	29.33
	8128197	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.67	CHEMBL5600	Homo sapiens	Inhibition	%	2.67
	8128364	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.88	CHEMBL5600	Homo sapiens	Inhibition	%	3.88
	8128588	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.01	CHEMBL5600	Homo sapiens	Inhibition	%	1.01
	8128707	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	29.57	CHEMBL5600	Homo sapiens	Inhibition	%	29.57
	8129068	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	6.69	CHEMBL5600	Homo sapiens	Inhibition	%	6.69
	8129239	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-5.74	CHEMBL5600	Homo sapiens	Inhibition	%	-5.74
	8129652	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.96	CHEMBL5600	Homo sapiens	Inhibition	%	2.96
	8129791	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.25	CHEMBL5600	Homo sapiens	Inhibition	%	1.25
	8130176	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.26	CHEMBL5600	Homo sapiens	Inhibition	%	-0.26
	8130348	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.76	CHEMBL5600	Homo sapiens	Inhibition	%	1.76
	8130732	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	24.71	CHEMBL5600	Homo sapiens	Inhibition	%	24.71
	8130848	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.71	CHEMBL5600	Homo sapiens	Inhibition	%	1.71
	8131211	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.99	CHEMBL5600	Homo sapiens	Inhibition	%	1.99
	8131555	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.87	CHEMBL5600	Homo sapiens	Inhibition	%	1.87
	8131722	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.56	CHEMBL5600	Homo sapiens	Inhibition	%	2.56
	8132087	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	5.23	CHEMBL5600	Homo sapiens	Inhibition	%	5.23
	8132373	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.34	CHEMBL5600	Homo sapiens	Inhibition	%	3.34
	8132520	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	13.73	CHEMBL5600	Homo sapiens	Inhibition	%	13.73
	8132912	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-4.55	CHEMBL5600	Homo sapiens	Inhibition	%	-4.55
	8133033	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.99	CHEMBL5600	Homo sapiens	Inhibition	%	0.99
	8133257	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.59	CHEMBL5600	Homo sapiens	Inhibition	%	2.59
	8133395	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.14	CHEMBL5600	Homo sapiens	Inhibition	%	2.14
	8133567	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.6	CHEMBL5600	Homo sapiens	Inhibition	%	-0.6
	8133791	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.32	CHEMBL5600	Homo sapiens	Inhibition	%	-2.32
	8133971	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	20.26	CHEMBL5600	Homo sapiens	Inhibition	%	20.26
	8134119	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.55	CHEMBL5600	Homo sapiens	Inhibition	%	-1.55
	8134343	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.01	CHEMBL5600	Homo sapiens	Inhibition	%	4.01
	8134503	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.61	CHEMBL5600	Homo sapiens	Inhibition	%	1.61
	8134687	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.83	CHEMBL5600	Homo sapiens	Inhibition	%	0.83
	8135071	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.15	CHEMBL5600	Homo sapiens	Inhibition	%	2.15
	8135186	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.04	CHEMBL5600	Homo sapiens	Inhibition	%	1.04
	8135410	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.87	CHEMBL5600	Homo sapiens	Inhibition	%	3.87
	8135551	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.11	CHEMBL5600	Homo sapiens	Inhibition	%	8.11
	8135896	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.38	CHEMBL5600	Homo sapiens	Inhibition	%	2.38
	8136064	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.24	CHEMBL5600	Homo sapiens	Inhibition	%	-0.24
	8136288	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.87	CHEMBL5600	Homo sapiens	Inhibition	%	0.87
	8136432	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.59	CHEMBL5600	Homo sapiens	Inhibition	%	3.59
	8136722	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.11	CHEMBL5600	Homo sapiens	Inhibition	%	4.11
	8136857	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.97	CHEMBL5600	Homo sapiens	Inhibition	%	2.97
	8137081	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	9.26	CHEMBL5600	Homo sapiens	Inhibition	%	9.26
	8137244	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.4	CHEMBL5600	Homo sapiens	Inhibition	%	3.4
	8137588	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.44	CHEMBL5600	Homo sapiens	Inhibition	%	0.44
	8137736	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.57	CHEMBL5600	Homo sapiens	Inhibition	%	2.57
	8138126	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.09	CHEMBL5600	Homo sapiens	Inhibition	%	3.09
	8138305	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.8	CHEMBL5600	Homo sapiens	Inhibition	%	0.8
	8138677	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.19	CHEMBL5600	Homo sapiens	Inhibition	%	0.19
	8138835	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.79	CHEMBL5600	Homo sapiens	Inhibition	%	1.79
	8139020	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	16.09	CHEMBL5600	Homo sapiens	Inhibition	%	16.09
	8139244	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.57	CHEMBL5600	Homo sapiens	Inhibition	%	-0.57
	8139403	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.09	CHEMBL5600	Homo sapiens	Inhibition	%	7.09
	8139741	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.16	CHEMBL5600	Homo sapiens	Inhibition	%	4.16
	8139882	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.31	CHEMBL5600	Homo sapiens	Inhibition	%	3.31
	8140106	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.78	CHEMBL5600	Homo sapiens	Inhibition	%	1.78
	8140229	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.78	CHEMBL5600	Homo sapiens	Inhibition	%	1.78
	8140612	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.73	CHEMBL5600	Homo sapiens	Inhibition	%	1.73
	8140755	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.12	CHEMBL5600	Homo sapiens	Inhibition	%	5.12
	8141057	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	4.35	CHEMBL5600	Homo sapiens	Inhibition	%	4.35
	8141411	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.27	CHEMBL5600	Homo sapiens	Inhibition	%	3.27
	8141571	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	9.23	CHEMBL5600	Homo sapiens	Inhibition	%	9.23
	8141914	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.0	CHEMBL5600	Homo sapiens	Inhibition	%	2.0
	8142075	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.0	CHEMBL5600	Homo sapiens	Inhibition	%	3.0
	8142299	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.83	CHEMBL5600	Homo sapiens	Inhibition	%	1.83
	8142467	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	6.29	CHEMBL5600	Homo sapiens	Inhibition	%	6.29
	8142643	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.92	CHEMBL5600	Homo sapiens	Inhibition	%	1.92
	8143016	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.42	CHEMBL5600	Homo sapiens	Inhibition	%	-0.42
	8143171	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.93	CHEMBL5600	Homo sapiens	Inhibition	%	2.93
	8143395	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.52	CHEMBL5600	Homo sapiens	Inhibition	%	2.52
	8143582	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.16	CHEMBL5600	Homo sapiens	Inhibition	%	2.16
	8143741	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-0.41	CHEMBL5600	Homo sapiens	Inhibition	%	-0.41
	8144079	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.89	CHEMBL5600	Homo sapiens	Inhibition	%	3.89
	8144442	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.67	CHEMBL5600	Homo sapiens	Inhibition	%	0.67
	8144572	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.41	CHEMBL5600	Homo sapiens	Inhibition	%	4.41
	8144949	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.91	CHEMBL5600	Homo sapiens	Inhibition	%	2.91
	8145086	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.94	CHEMBL5600	Homo sapiens	Inhibition	%	3.94
	8145310	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.8	CHEMBL5600	Homo sapiens	Inhibition	%	5.8
	8145399	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	6.25	CHEMBL5600	Homo sapiens	Inhibition	%	6.25
	8145747	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.53	CHEMBL5600	Homo sapiens	Inhibition	%	1.53
	8145908	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.64	CHEMBL5600	Homo sapiens	Inhibition	%	2.64
	8146132	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	13.27	CHEMBL5600	Homo sapiens	Inhibition	%	13.27
	8146252	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.35	CHEMBL5600	Homo sapiens	Inhibition	%	1.35
	8146636	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.11	CHEMBL5600	Homo sapiens	Inhibition	%	2.11
	8146803	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	57.64	CHEMBL5600	Homo sapiens	Inhibition	%	57.64
	8146972	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.59	CHEMBL5600	Homo sapiens	Inhibition	%	-0.59
	8147196	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.23	CHEMBL5600	Homo sapiens	Inhibition	%	3.23
	8147338	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.77	CHEMBL5600	Homo sapiens	Inhibition	%	3.77
	8147715	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.72	CHEMBL5600	Homo sapiens	Inhibition	%	0.72
	8147902	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-2.9	CHEMBL5600	Homo sapiens	Inhibition	%	-2.9
	8148060	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.93	CHEMBL5600	Homo sapiens	Inhibition	%	3.93
	8148284	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.16	CHEMBL5600	Homo sapiens	Inhibition	%	1.16
	8148398	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.13	CHEMBL5600	Homo sapiens	Inhibition	%	-0.13
	8148761	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.9	CHEMBL5600	Homo sapiens	Inhibition	%	0.9
	8148899	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.42	CHEMBL5600	Homo sapiens	Inhibition	%	3.42
	8149123	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.64	CHEMBL5600	Homo sapiens	Inhibition	%	6.64
	8149282	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1	Outside typical range	CHEMBL384407	=	Inhibition	%	-10.48	CHEMBL5600	Homo sapiens	Inhibition	%	-10.48
	8149640	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.81	CHEMBL5600	Homo sapiens	Inhibition	%	1.81
	8149738	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.32	CHEMBL5600	Homo sapiens	Inhibition	%	3.32
	8149962	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.19	CHEMBL5600	Homo sapiens	Inhibition	%	5.19
	8150087	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.52	CHEMBL5600	Homo sapiens	Inhibition	%	-0.52
	8150471	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.07	CHEMBL5600	Homo sapiens	Inhibition	%	1.07
	8150591	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.81	CHEMBL5600	Homo sapiens	Inhibition	%	1.81
	8150980	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.97	CHEMBL5600	Homo sapiens	Inhibition	%	4.97
	8151143	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.64	CHEMBL5600	Homo sapiens	Inhibition	%	1.64
	8151544	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.47	CHEMBL5600	Homo sapiens	Inhibition	%	0.47
	8151682	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.86	CHEMBL5600	Homo sapiens	Inhibition	%	1.86
	8152060	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.49	CHEMBL5600	Homo sapiens	Inhibition	%	3.49
	8152248	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.71	CHEMBL5600	Homo sapiens	Inhibition	%	3.71
	8152630	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.02	CHEMBL5600	Homo sapiens	Inhibition	%	4.02
	8152744	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.81	CHEMBL5600	Homo sapiens	Inhibition	%	3.81
	8152968	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.79	CHEMBL5600	Homo sapiens	Inhibition	%	3.79
	8153107	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.67	CHEMBL5600	Homo sapiens	Inhibition	%	1.67
	8153468	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.76	CHEMBL5600	Homo sapiens	Inhibition	%	5.76
	8153625	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.24	CHEMBL5600	Homo sapiens	Inhibition	%	-0.24
	8153982	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	16.59	CHEMBL5600	Homo sapiens	Inhibition	%	16.59
	8154303	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.42	CHEMBL5600	Homo sapiens	Inhibition	%	3.42
	8154429	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.23	CHEMBL5600	Homo sapiens	Inhibition	%	-0.23
	8154812	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	23.19	CHEMBL5600	Homo sapiens	Inhibition	%	23.19
	8154932	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.6	CHEMBL5600	Homo sapiens	Inhibition	%	-0.6
	8155156	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.35	CHEMBL5600	Homo sapiens	Inhibition	%	0.35
	8155332	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.09	CHEMBL5600	Homo sapiens	Inhibition	%	-0.09
	8155493	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	5.49	CHEMBL5600	Homo sapiens	Inhibition	%	5.49
	8155717	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.73	CHEMBL5600	Homo sapiens	Inhibition	%	3.73
	8155895	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.36	CHEMBL5600	Homo sapiens	Inhibition	%	3.36
	8156033	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.6	CHEMBL5600	Homo sapiens	Inhibition	%	1.6
	8156257	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.96	CHEMBL5600	Homo sapiens	Inhibition	%	0.96
	8156469	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.78	CHEMBL5600	Homo sapiens	Inhibition	%	3.78
	8156619	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	10.14	CHEMBL5600	Homo sapiens	Inhibition	%	10.14
	8156843	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.81	CHEMBL5600	Homo sapiens	Inhibition	%	2.81
	8156986	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	12.16	CHEMBL5600	Homo sapiens	Inhibition	%	12.16
	8157330	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.26	CHEMBL5600	Homo sapiens	Inhibition	%	5.26
	8157471	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.84	CHEMBL5600	Homo sapiens	Inhibition	%	1.84
	8157825	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.52	CHEMBL5600	Homo sapiens	Inhibition	%	6.52
	8157986	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.06	CHEMBL5600	Homo sapiens	Inhibition	%	2.06
	8158210	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	5.08	CHEMBL5600	Homo sapiens	Inhibition	%	5.08
	8158236	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.48	CHEMBL5600	Homo sapiens	Inhibition	%	2.48
	8158460	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.75	CHEMBL5600	Homo sapiens	Inhibition	%	3.75
	8158618	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.65	CHEMBL5600	Homo sapiens	Inhibition	%	0.65
	8158787	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.76	CHEMBL5600	Homo sapiens	Inhibition	%	2.76
	8159011	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.14	CHEMBL5600	Homo sapiens	Inhibition	%	-0.14
	8159146	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.14	CHEMBL5600	Homo sapiens	Inhibition	%	1.14
	8159490	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.44	CHEMBL5600	Homo sapiens	Inhibition	%	1.44
	8159621	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	32.54	CHEMBL5600	Homo sapiens	Inhibition	%	32.54
	8159845	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	19.87	CHEMBL5600	Homo sapiens	Inhibition	%	19.87
	8159986	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.15	CHEMBL5600	Homo sapiens	Inhibition	%	4.15
	8160347	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.29	CHEMBL5600	Homo sapiens	Inhibition	%	5.29
	8160497	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.63	CHEMBL5600	Homo sapiens	Inhibition	%	-1.63
	8160791	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.2	CHEMBL5600	Homo sapiens	Inhibition	%	7.2
	8161165	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	9.85	CHEMBL5600	Homo sapiens	Inhibition	%	9.85
	8161308	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.06	CHEMBL5600	Homo sapiens	Inhibition	%	5.06
	8161657	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.72	CHEMBL5600	Homo sapiens	Inhibition	%	1.72
	8161795	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	7.63	CHEMBL5600	Homo sapiens	Inhibition	%	7.63
	8162019	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.25	CHEMBL5600	Homo sapiens	Inhibition	%	5.25
	8162149	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	28.33	CHEMBL5600	Homo sapiens	Inhibition	%	28.33
	8162533	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.11	CHEMBL5600	Homo sapiens	Inhibition	%	0.11
	8162786	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.57	CHEMBL5600	Homo sapiens	Inhibition	%	4.57
	8162934	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	17.8	CHEMBL5600	Homo sapiens	Inhibition	%	17.8
	8163327	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.5	CHEMBL5600	Homo sapiens	Inhibition	%	2.5
	8163461	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	10.05	CHEMBL5600	Homo sapiens	Inhibition	%	10.05
	8163685	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.41	CHEMBL5600	Homo sapiens	Inhibition	%	2.41
	8163808	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	11.89	CHEMBL5600	Homo sapiens	Inhibition	%	11.89
	8164166	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	68.34	CHEMBL5600	Homo sapiens	Inhibition	%	68.34
	8164306	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.34	CHEMBL5600	Homo sapiens	Inhibition	%	1.34
	8164685	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.34	CHEMBL5600	Homo sapiens	Inhibition	%	2.34
	8164829	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.22	CHEMBL5600	Homo sapiens	Inhibition	%	0.22
	8165053	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.47	CHEMBL5600	Homo sapiens	Inhibition	%	3.47
	8165123	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.9	CHEMBL5600	Homo sapiens	Inhibition	%	5.9
	8165488	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.68	CHEMBL5600	Homo sapiens	Inhibition	%	-0.68
	8165631	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	24.83	CHEMBL5600	Homo sapiens	Inhibition	%	24.83
	8165855	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.3	CHEMBL5600	Homo sapiens	Inhibition	%	3.3
	8165981	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	13.62	CHEMBL5600	Homo sapiens	Inhibition	%	13.62
	8166343	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	18.99	CHEMBL5600	Homo sapiens	Inhibition	%	18.99
	8166473	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.78	CHEMBL5600	Homo sapiens	Inhibition	%	3.78
	8166798	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	9.39	CHEMBL5600	Homo sapiens	Inhibition	%	9.39
	8167110	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.46	CHEMBL5600	Homo sapiens	Inhibition	%	0.46
	8167251	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	60.66	CHEMBL5600	Homo sapiens	Inhibition	%	60.66
	8167475	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.88	CHEMBL5600	Homo sapiens	Inhibition	%	5.88
	8167639	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.94	CHEMBL5600	Homo sapiens	Inhibition	%	0.94
	8167996	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.73	CHEMBL5600	Homo sapiens	Inhibition	%	3.73
	8168120	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.23	CHEMBL5600	Homo sapiens	Inhibition	%	0.23
	8168485	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.33	CHEMBL5600	Homo sapiens	Inhibition	%	4.33
	8168621	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.48	CHEMBL5600	Homo sapiens	Inhibition	%	1.48
	8168845	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.87	CHEMBL5600	Homo sapiens	Inhibition	%	2.87
	8169009	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	13.11	CHEMBL5600	Homo sapiens	Inhibition	%	13.11
	8169375	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.81	CHEMBL5600	Homo sapiens	Inhibition	%	0.81
	8169455	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.77	CHEMBL5600	Homo sapiens	Inhibition	%	3.77
	8169679	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.6	CHEMBL5600	Homo sapiens	Inhibition	%	8.6
	8169813	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	6.23	CHEMBL5600	Homo sapiens	Inhibition	%	6.23
	8170182	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.35	CHEMBL5600	Homo sapiens	Inhibition	%	2.35
	8170307	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.64	CHEMBL5600	Homo sapiens	Inhibition	%	2.64
	8170671	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	13.04	CHEMBL5600	Homo sapiens	Inhibition	%	13.04
	8170806	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.43	CHEMBL5600	Homo sapiens	Inhibition	%	6.43
	8171030	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.56	CHEMBL5600	Homo sapiens	Inhibition	%	2.56
	8171227	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.33	CHEMBL5600	Homo sapiens	Inhibition	%	3.33
	8171444	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	8.24	CHEMBL5600	Homo sapiens	Inhibition	%	8.24
	8171809	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.59	CHEMBL5600	Homo sapiens	Inhibition	%	7.59
	8171962	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.17	CHEMBL5600	Homo sapiens	Inhibition	%	0.17
	8172318	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.47	CHEMBL5600	Homo sapiens	Inhibition	%	2.47
	8172446	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	8.67	CHEMBL5600	Homo sapiens	Inhibition	%	8.67
	8172670	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.18	CHEMBL5600	Homo sapiens	Inhibition	%	-0.18
	8172812	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	21.94	CHEMBL5600	Homo sapiens	Inhibition	%	21.94
	8173172	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.86	CHEMBL5600	Homo sapiens	Inhibition	%	3.86
	8173337	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.75	CHEMBL5600	Homo sapiens	Inhibition	%	5.75
	8173702	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.31	CHEMBL5600	Homo sapiens	Inhibition	%	4.31
	8174013	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	49.15	CHEMBL5600	Homo sapiens	Inhibition	%	49.15
	8174145	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.68	CHEMBL5600	Homo sapiens	Inhibition	%	2.68
	8174517	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.12	CHEMBL5600	Homo sapiens	Inhibition	%	4.12
	8174639	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.38	CHEMBL5600	Homo sapiens	Inhibition	%	2.38
	8174863	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.76	CHEMBL5600	Homo sapiens	Inhibition	%	2.76
	8175006	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	68.75	CHEMBL5600	Homo sapiens	Inhibition	%	68.75
	8175366	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.95	CHEMBL5600	Homo sapiens	Inhibition	%	3.95
	8175622	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	36.4	CHEMBL5600	Homo sapiens	Inhibition	%	36.4
	8175785	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.92	CHEMBL5600	Homo sapiens	Inhibition	%	0.92
	8176009	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-2.37	CHEMBL5600	Homo sapiens	Inhibition	%	-2.37
	8176162	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.76	CHEMBL5600	Homo sapiens	Inhibition	%	5.76
	8176311	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.64	CHEMBL5600	Homo sapiens	Inhibition	%	-1.64
	8176535	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	6.41	CHEMBL5600	Homo sapiens	Inhibition	%	6.41
	8176667	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	27.5	CHEMBL5600	Homo sapiens	Inhibition	%	27.5
	8177021	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	6.87	CHEMBL5600	Homo sapiens	Inhibition	%	6.87
	8177163	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.87	CHEMBL5600	Homo sapiens	Inhibition	%	5.87
	8177387	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.96	CHEMBL5600	Homo sapiens	Inhibition	%	5.96
	8177525	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.92	CHEMBL5600	Homo sapiens	Inhibition	%	3.92
	8177689	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.7	CHEMBL5600	Homo sapiens	Inhibition	%	7.7
	8177913	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.4	CHEMBL5600	Homo sapiens	Inhibition	%	3.4
	8178053	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	6.43	CHEMBL5600	Homo sapiens	Inhibition	%	6.43
	8178365	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.14	CHEMBL5600	Homo sapiens	Inhibition	%	2.14
	8178492	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.01	CHEMBL5600	Homo sapiens	Inhibition	%	2.01
	8178716	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.91	CHEMBL5600	Homo sapiens	Inhibition	%	4.91
	8178865	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	6.77	CHEMBL5600	Homo sapiens	Inhibition	%	6.77
	8179212	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.72	CHEMBL5600	Homo sapiens	Inhibition	%	2.72
	8179356	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.2	CHEMBL5600	Homo sapiens	Inhibition	%	4.2
	8179580	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	34.41	CHEMBL5600	Homo sapiens	Inhibition	%	34.41
	8179717	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-1.25	CHEMBL5600	Homo sapiens	Inhibition	%	-1.25
	8179974	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.75	CHEMBL5600	Homo sapiens	Inhibition	%	3.75
	8180352	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.42	CHEMBL5600	Homo sapiens	Inhibition	%	-1.42
	8180508	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	22.65	CHEMBL5600	Homo sapiens	Inhibition	%	22.65
	8180880	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	32.72	CHEMBL5600	Homo sapiens	Inhibition	%	32.72
	8181013	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.7	CHEMBL5600	Homo sapiens	Inhibition	%	2.7
	8181368	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.37	CHEMBL5600	Homo sapiens	Inhibition	%	2.37
	8181732	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.89	CHEMBL5600	Homo sapiens	Inhibition	%	5.89
	8181871	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	33.5	CHEMBL5600	Homo sapiens	Inhibition	%	33.5
	8182258	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.12	CHEMBL5600	Homo sapiens	Inhibition	%	3.12
	8182398	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.28	CHEMBL5600	Homo sapiens	Inhibition	%	3.28
	8182714	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.81	CHEMBL5600	Homo sapiens	Inhibition	%	3.81
	8183060	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.87	CHEMBL5600	Homo sapiens	Inhibition	%	6.87
	8183209	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.96	CHEMBL5600	Homo sapiens	Inhibition	%	3.96
	8183433	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.05	CHEMBL5600	Homo sapiens	Inhibition	%	2.05
	8183562	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.66	CHEMBL5600	Homo sapiens	Inhibition	%	5.66
	8183928	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.4	CHEMBL5600	Homo sapiens	Inhibition	%	4.4
	8184064	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.4	CHEMBL5600	Homo sapiens	Inhibition	%	-0.4
	8184330	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.62	CHEMBL5600	Homo sapiens	Inhibition	%	4.62
	8184701	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.25	CHEMBL5600	Homo sapiens	Inhibition	%	-1.25
	8184858	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.24	CHEMBL5600	Homo sapiens	Inhibition	%	4.24
	8185082	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-0.42	CHEMBL5600	Homo sapiens	Inhibition	%	-0.42
	8185231	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.71	CHEMBL5600	Homo sapiens	Inhibition	%	1.71
	8185362	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.85	CHEMBL5600	Homo sapiens	Inhibition	%	4.85
	8185586	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.17	CHEMBL5600	Homo sapiens	Inhibition	%	5.17
	8185717	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	19.84	CHEMBL5600	Homo sapiens	Inhibition	%	19.84
	8186080	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	9.09	CHEMBL5600	Homo sapiens	Inhibition	%	9.09
	8186221	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.11	CHEMBL5600	Homo sapiens	Inhibition	%	4.11
	8186445	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	10.46	CHEMBL5600	Homo sapiens	Inhibition	%	10.46
	8186609	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.65	CHEMBL5600	Homo sapiens	Inhibition	%	3.65
	8186748	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.91	CHEMBL5600	Homo sapiens	Inhibition	%	3.91
	8186972	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.51	CHEMBL5600	Homo sapiens	Inhibition	%	6.51
	8187070	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.52	CHEMBL5600	Homo sapiens	Inhibition	%	3.52
	8187418	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.91	CHEMBL5600	Homo sapiens	Inhibition	%	0.91
	8187790	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.86	CHEMBL5600	Homo sapiens	Inhibition	%	3.86
	8187919	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	11.21	CHEMBL5600	Homo sapiens	Inhibition	%	11.21
	8188286	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	13.22	CHEMBL5600	Homo sapiens	Inhibition	%	13.22
	8188421	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.34	CHEMBL5600	Homo sapiens	Inhibition	%	0.34
	8188645	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.26	CHEMBL5600	Homo sapiens	Inhibition	%	4.26
	8188695	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.64	CHEMBL5600	Homo sapiens	Inhibition	%	1.64
	8188919	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.44	CHEMBL5600	Homo sapiens	Inhibition	%	0.44
	8189067	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.28	CHEMBL5600	Homo sapiens	Inhibition	%	0.28
	8189447	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.23	CHEMBL5600	Homo sapiens	Inhibition	%	5.23
	8189596	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.66	CHEMBL5600	Homo sapiens	Inhibition	%	1.66
	8189952	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.08	CHEMBL5600	Homo sapiens	Inhibition	%	6.08
	8190084	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.34	CHEMBL5600	Homo sapiens	Inhibition	%	3.34
	8190308	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.27	CHEMBL5600	Homo sapiens	Inhibition	%	1.27
	8190448	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.42	CHEMBL5600	Homo sapiens	Inhibition	%	5.42
	8190809	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.03	CHEMBL5600	Homo sapiens	Inhibition	%	4.03
	8190973	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.14	CHEMBL5600	Homo sapiens	Inhibition	%	4.14
	8191335	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.62	CHEMBL5600	Homo sapiens	Inhibition	%	6.62
	8191431	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.59	CHEMBL5600	Homo sapiens	Inhibition	%	3.59
	8191655	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.04	CHEMBL5600	Homo sapiens	Inhibition	%	1.04
	8191777	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.67	CHEMBL5600	Homo sapiens	Inhibition	%	6.67
	8192150	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.43	CHEMBL5600	Homo sapiens	Inhibition	%	0.43
	8192279	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.55	CHEMBL5600	Homo sapiens	Inhibition	%	1.55
	8192503	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.99	CHEMBL5600	Homo sapiens	Inhibition	%	0.99
	8192647	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.94	CHEMBL5600	Homo sapiens	Inhibition	%	3.94
	8193007	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-1.2	CHEMBL5600	Homo sapiens	Inhibition	%	-1.2
	8193279	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.27	CHEMBL5600	Homo sapiens	Inhibition	%	3.27
	8193424	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.41	CHEMBL5600	Homo sapiens	Inhibition	%	0.41
	8193805	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	17.0	CHEMBL5600	Homo sapiens	Inhibition	%	17.0
	8193954	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.92	CHEMBL5600	Homo sapiens	Inhibition	%	1.92
	8194178	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.19	CHEMBL5600	Homo sapiens	Inhibition	%	-0.19
	8194309	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.06	CHEMBL5600	Homo sapiens	Inhibition	%	4.06
	8194664	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.98	CHEMBL5600	Homo sapiens	Inhibition	%	5.98
	8194807	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	11.93	CHEMBL5600	Homo sapiens	Inhibition	%	11.93
	8195164	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.04	CHEMBL5600	Homo sapiens	Inhibition	%	6.04
	8195328	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.74	CHEMBL5600	Homo sapiens	Inhibition	%	4.74
	8195552	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	8.65	CHEMBL5600	Homo sapiens	Inhibition	%	8.65
	8195691	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.6	CHEMBL5600	Homo sapiens	Inhibition	%	4.6
	8196013	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.71	CHEMBL5600	Homo sapiens	Inhibition	%	1.71
	8196130	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.67	CHEMBL5600	Homo sapiens	Inhibition	%	1.67
	8196354	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.72	CHEMBL5600	Homo sapiens	Inhibition	%	3.72
	8196504	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.81	CHEMBL5600	Homo sapiens	Inhibition	%	3.81
	8196856	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.86	CHEMBL5600	Homo sapiens	Inhibition	%	3.86
	8196997	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.03	CHEMBL5600	Homo sapiens	Inhibition	%	6.03
	8197358	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.83	CHEMBL5600	Homo sapiens	Inhibition	%	-0.83
	8197633	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-2.7	CHEMBL5600	Homo sapiens	Inhibition	%	-2.7
	8197773	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.85	CHEMBL5600	Homo sapiens	Inhibition	%	1.85
	8197997	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	9.99	CHEMBL5600	Homo sapiens	Inhibition	%	9.99
	8198154	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.87	CHEMBL5600	Homo sapiens	Inhibition	%	3.87
	8198516	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.52	CHEMBL5600	Homo sapiens	Inhibition	%	2.52
	8198646	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.46	CHEMBL5600	Homo sapiens	Inhibition	%	6.46
	8199001	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.11	CHEMBL5600	Homo sapiens	Inhibition	%	2.11
	8199149	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.84	CHEMBL5600	Homo sapiens	Inhibition	%	3.84
	8199373	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.0	CHEMBL5600	Homo sapiens	Inhibition	%	5.0
	8199507	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.58	CHEMBL5600	Homo sapiens	Inhibition	%	4.58
	8199894	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.5	CHEMBL5600	Homo sapiens	Inhibition	%	2.5
	8200032	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.42	CHEMBL5600	Homo sapiens	Inhibition	%	4.42
	8200360	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-2.23	CHEMBL5600	Homo sapiens	Inhibition	%	-2.23
	8200699	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.13	CHEMBL5600	Homo sapiens	Inhibition	%	7.13
	8200849	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.65	CHEMBL5600	Homo sapiens	Inhibition	%	0.65
	8201203	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	20.26	CHEMBL5600	Homo sapiens	Inhibition	%	20.26
	8201338	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.26	CHEMBL5600	Homo sapiens	Inhibition	%	-0.26
	8201562	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.1	CHEMBL5600	Homo sapiens	Inhibition	%	0.1
	8201695	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.61	CHEMBL5600	Homo sapiens	Inhibition	%	0.61
	8201974	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.95	CHEMBL5600	Homo sapiens	Inhibition	%	1.95
	8202338	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.72	CHEMBL5600	Homo sapiens	Inhibition	%	-0.72
	8202505	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.12	CHEMBL5600	Homo sapiens	Inhibition	%	-0.12
	8202854	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.81	CHEMBL5600	Homo sapiens	Inhibition	%	0.81
	8202984	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.73	CHEMBL5600	Homo sapiens	Inhibition	%	2.73
	8203208	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.44	CHEMBL5600	Homo sapiens	Inhibition	%	10.44
	8203339	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	5.31	CHEMBL5600	Homo sapiens	Inhibition	%	5.31
	8203709	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.58	CHEMBL5600	Homo sapiens	Inhibition	%	2.58
	8203843	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.26	CHEMBL5600	Homo sapiens	Inhibition	%	4.26
	8204067	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.15	CHEMBL5600	Homo sapiens	Inhibition	%	5.15
	8204233	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.89	CHEMBL5600	Homo sapiens	Inhibition	%	1.89
	8204370	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.39	CHEMBL5600	Homo sapiens	Inhibition	%	4.39
	8204594	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	10.79	CHEMBL5600	Homo sapiens	Inhibition	%	10.79
	8204699	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	8.43	CHEMBL5600	Homo sapiens	Inhibition	%	8.43
	8205038	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	30.6	CHEMBL5600	Homo sapiens	Inhibition	%	30.6
	8205187	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.76	CHEMBL5600	Homo sapiens	Inhibition	%	4.76
	8205411	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	12.94	CHEMBL5600	Homo sapiens	Inhibition	%	12.94
	8205547	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.53	CHEMBL5600	Homo sapiens	Inhibition	%	1.53
	8205910	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.42	CHEMBL5600	Homo sapiens	Inhibition	%	2.42
	8206042	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.9	CHEMBL5600	Homo sapiens	Inhibition	%	-1.9
	8206266	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.0	CHEMBL5600	Homo sapiens	Inhibition	%	1.0
	8206318	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-2.72	CHEMBL5600	Homo sapiens	Inhibition	%	-2.72
	8206542	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.14	CHEMBL5600	Homo sapiens	Inhibition	%	0.14
	8206685	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.49	CHEMBL5600	Homo sapiens	Inhibition	%	-2.49
	8206865	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.25	CHEMBL5600	Homo sapiens	Inhibition	%	4.25
	8207089	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.45	CHEMBL5600	Homo sapiens	Inhibition	%	3.45
	8207215	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.28	CHEMBL5600	Homo sapiens	Inhibition	%	2.28
	8207569	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	3.96	CHEMBL5600	Homo sapiens	Inhibition	%	3.96
	8207701	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	5.76	CHEMBL5600	Homo sapiens	Inhibition	%	5.76
	8207925	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.98	CHEMBL5600	Homo sapiens	Inhibition	%	5.98
	8208070	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.34	CHEMBL5600	Homo sapiens	Inhibition	%	-0.34
	8208426	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.51	CHEMBL5600	Homo sapiens	Inhibition	%	5.51
	8208592	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.58	CHEMBL5600	Homo sapiens	Inhibition	%	0.58
	8208949	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.63	CHEMBL5600	Homo sapiens	Inhibition	%	7.63
	8209054	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.41	CHEMBL5600	Homo sapiens	Inhibition	%	-0.41
	8209278	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	7.39	CHEMBL5600	Homo sapiens	Inhibition	%	7.39
	8209394	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.5	CHEMBL5600	Homo sapiens	Inhibition	%	2.5
	8209768	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.65	CHEMBL5600	Homo sapiens	Inhibition	%	2.65
	8209904	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.66	CHEMBL5600	Homo sapiens	Inhibition	%	9.66
	8210128	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.47	CHEMBL5600	Homo sapiens	Inhibition	%	3.47
	8210269	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.71	CHEMBL5600	Homo sapiens	Inhibition	%	1.71
	8210629	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.75	CHEMBL5600	Homo sapiens	Inhibition	%	-0.75
	8210888	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.1	CHEMBL5600	Homo sapiens	Inhibition	%	-1.1
	8211032	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.38	CHEMBL5600	Homo sapiens	Inhibition	%	2.38
	8211426	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.37	CHEMBL5600	Homo sapiens	Inhibition	%	1.37
	8211549	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	6.68	CHEMBL5600	Homo sapiens	Inhibition	%	6.68
	8211902	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.75	CHEMBL5600	Homo sapiens	Inhibition	%	8.75
	8212258	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	9.67	CHEMBL5600	Homo sapiens	Inhibition	%	9.67
	8212399	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.03	CHEMBL5600	Homo sapiens	Inhibition	%	2.03
	8212756	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.12	CHEMBL5600	Homo sapiens	Inhibition	%	4.12
	8212926	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.13	CHEMBL5600	Homo sapiens	Inhibition	%	4.13
	8213279	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	22.62	CHEMBL5600	Homo sapiens	Inhibition	%	22.62
	8213607	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.12	CHEMBL5600	Homo sapiens	Inhibition	%	-0.12
	8213720	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	8.13	CHEMBL5600	Homo sapiens	Inhibition	%	8.13
	8213944	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.63	CHEMBL5600	Homo sapiens	Inhibition	%	2.63
	8214091	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.56	CHEMBL5600	Homo sapiens	Inhibition	%	5.56
	8214452	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	37.18	CHEMBL5600	Homo sapiens	Inhibition	%	37.18
	8214586	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.15	CHEMBL5600	Homo sapiens	Inhibition	%	4.15
	8214962	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.18	CHEMBL5600	Homo sapiens	Inhibition	%	7.18
	8215213	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.18	CHEMBL5600	Homo sapiens	Inhibition	%	2.18
	8215366	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.04	CHEMBL5600	Homo sapiens	Inhibition	%	3.04
	8215590	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.6	CHEMBL5600	Homo sapiens	Inhibition	%	5.6
	8215754	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.49	CHEMBL5600	Homo sapiens	Inhibition	%	1.49
	8215873	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.03	CHEMBL5600	Homo sapiens	Inhibition	%	1.03
	8216097	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	19.63	CHEMBL5600	Homo sapiens	Inhibition	%	19.63
	8216216	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.94	CHEMBL5600	Homo sapiens	Inhibition	%	0.94
	8216576	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.19	CHEMBL5600	Homo sapiens	Inhibition	%	7.19
	8216714	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.76	CHEMBL5600	Homo sapiens	Inhibition	%	4.76
	8216938	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.91	CHEMBL5600	Homo sapiens	Inhibition	%	5.91
	8217072	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.47	CHEMBL5600	Homo sapiens	Inhibition	%	7.47
	8217246	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.01	CHEMBL5600	Homo sapiens	Inhibition	%	-0.01
	8217470	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.43	CHEMBL5600	Homo sapiens	Inhibition	%	-0.43
	8217601	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	49.58	CHEMBL5600	Homo sapiens	Inhibition	%	49.58
	8217926	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.91	CHEMBL5600	Homo sapiens	Inhibition	%	1.91
	8218265	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.44	CHEMBL5600	Homo sapiens	Inhibition	%	4.44
	8218392	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.78	CHEMBL5600	Homo sapiens	Inhibition	%	4.78
	8218759	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.75	CHEMBL5600	Homo sapiens	Inhibition	%	0.75
	8218890	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	12.5	CHEMBL5600	Homo sapiens	Inhibition	%	12.5
	8219114	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.79	CHEMBL5600	Homo sapiens	Inhibition	%	3.79
	8219274	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.45	CHEMBL5600	Homo sapiens	Inhibition	%	5.45
	8219524	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	8.72	CHEMBL5600	Homo sapiens	Inhibition	%	8.72
	8219909	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-0.28	CHEMBL5600	Homo sapiens	Inhibition	%	-0.28
	8220078	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.19	CHEMBL5600	Homo sapiens	Inhibition	%	1.19
	8220431	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.24	CHEMBL5600	Homo sapiens	Inhibition	%	4.24
	8220545	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	11.51	CHEMBL5600	Homo sapiens	Inhibition	%	11.51
	8220769	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.36	CHEMBL5600	Homo sapiens	Inhibition	%	3.36
	8220907	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	40.1	CHEMBL5600	Homo sapiens	Inhibition	%	40.1
	8221267	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	18.99	CHEMBL5600	Homo sapiens	Inhibition	%	18.99
	8221400	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.95	CHEMBL5600	Homo sapiens	Inhibition	%	4.95
	8221789	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.2	CHEMBL5600	Homo sapiens	Inhibition	%	-0.2
	8221920	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	88.26	CHEMBL5600	Homo sapiens	Inhibition	%	88.26
	8222144	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.09	CHEMBL5600	Homo sapiens	Inhibition	%	4.09
	8222242	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.57	CHEMBL5600	Homo sapiens	Inhibition	%	0.57
	8222600	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.38	CHEMBL5600	Homo sapiens	Inhibition	%	4.38
	8222718	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	18.36	CHEMBL5600	Homo sapiens	Inhibition	%	18.36
	8222942	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-1.82	CHEMBL5600	Homo sapiens	Inhibition	%	-1.82
	8223086	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	5.58	CHEMBL5600	Homo sapiens	Inhibition	%	5.58
	8223439	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	22.88	CHEMBL5600	Homo sapiens	Inhibition	%	22.88
	8223600	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.54	CHEMBL5600	Homo sapiens	Inhibition	%	4.54
	8223850	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.58	CHEMBL5600	Homo sapiens	Inhibition	%	1.58
	8224236	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.19	CHEMBL5600	Homo sapiens	Inhibition	%	6.19
	8224406	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-4.11	CHEMBL5600	Homo sapiens	Inhibition	%	-4.11
	8224765	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.18	CHEMBL5600	Homo sapiens	Inhibition	%	6.18
	8225103	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	9.91	CHEMBL5600	Homo sapiens	Inhibition	%	9.91
	8225237	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.96	CHEMBL5600	Homo sapiens	Inhibition	%	5.96
	8225599	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.01	CHEMBL5600	Homo sapiens	Inhibition	%	2.01
	8225734	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.97	CHEMBL5600	Homo sapiens	Inhibition	%	4.97
	8225958	CHEMBL1961974	GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.14	CHEMBL5600	Homo sapiens	Inhibition	%	4.14
	8226116	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.22	CHEMBL5600	Homo sapiens	Inhibition	%	-2.22
	8226465	CHEMBL1961975	GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	11.21	CHEMBL5600	Homo sapiens	Inhibition	%	11.21
active	9572086	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9572087	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572088	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9572089	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9572090	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572091	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572092	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	31.62	CHEMBL5600	Homo sapiens	pKi		7.5
active	9572093	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9572094	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572095	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9572096	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	100.0	CHEMBL5600	Homo sapiens	pKi		7.0
inactive	9572097	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572098	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
inactive	9572099	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572100	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572101	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
active	9572102	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9572103	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	50.12	CHEMBL5600	Homo sapiens	pKi		7.3
inactive	9572104	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9572105	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572106	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	158.49	CHEMBL5600	Homo sapiens	pKi		6.8
inactive	9572107	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572108	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572109	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572110	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572111	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
active	9572112	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9572113	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572114	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572115	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	100.0	CHEMBL5600	Homo sapiens	pKi		7.0
active	9572116	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	50.12	CHEMBL5600	Homo sapiens	pKi		7.3
inactive	9572117	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572118	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccccc1-c1cccc2c1c(Nc1ccccc1)c(C(=O)O)n2CCCOc1cccc2ccccc12		CHEMBL2001646	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9572119	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572120	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9572121	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9572122	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572123	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572124	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572125	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572126	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572127	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9572128	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572129	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572130	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572131	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9572132	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
active	9572133	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9572134	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9572135	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572136	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572137	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572138	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572139	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572140	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572141	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9572142	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
active	9572143	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
active	9572144	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9572145	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9572146	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572147	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9572148	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
active	9572149	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	50.12	CHEMBL5600	Homo sapiens	pKi		7.3
inactive	9572150	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572151	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572152	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9572153	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572154	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572155	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572156	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572157	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572158	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572159	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572160	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9572161	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572162	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572163	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572164	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9572165	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572166	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9572167	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572168	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	100.0	CHEMBL5600	Homo sapiens	pKi		7.0
active	9572169	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9572170	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572171	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572172	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1C(F)(F)F		CHEMBL1981947	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572173	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9572174	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572175	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572176	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572177	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9572178	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572179	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9572180	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
active	9572181	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9572182	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572183	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572184	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572185	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572186	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572187	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	63.1	CHEMBL5600	Homo sapiens	pKi		7.2
inactive	9572188	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572189	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572190	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572191	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9572192	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572193	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9572194	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572195	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572196	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9572197	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9572198	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9572199	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572200	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9572201	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9572202	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9572203	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
active	9572204	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9572205	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9572206	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572207	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572208	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9572209	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9572210	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572211	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572212	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572213	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572214	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572215	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9572216	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9572217	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9572218	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
active	9572219	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9575801	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575802	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575803	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575804	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9575805	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575806	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575807	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
inactive	9575808	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575809	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575810	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575811	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575812	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575813	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9575814	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(Nc2c(C(=O)O)n(CCCOc3cccc4ccccc34)c3cccc(-c4ccccc4C)c23)cc1		CHEMBL1978645	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9575815	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575816	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575817	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575818	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575819	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9575820	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
inactive	9575821	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575822	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9575823	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575824	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575825	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9575826	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9575827	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9575828	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575829	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575830	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575831	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575832	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575833	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575834	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575835	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575836	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575837	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575838	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575839	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575840	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575841	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9575842	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575843	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
inactive	9575844	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575845	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
active	9575846	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
active	9575847	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575848	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575849	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575850	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575851	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575852	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575853	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575854	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
inactive	9575855	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575856	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9575857	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575858	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575859	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	7943.28	CHEMBL5600	Homo sapiens	pKi		5.1
inactive	9575860	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575861	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575862	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575863	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575864	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575865	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575866	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575867	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9575868	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9575869	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575870	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575871	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575872	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575873	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9575874	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575875	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575876	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575877	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575878	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9575879	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575880	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575881	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575882	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575883	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575884	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575885	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	0.3981	CHEMBL5600	Homo sapiens	pKi		9.4
active	9575886	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9575887	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9575888	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9575889	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9575890	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575891	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9575892	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575893	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575894	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575895	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575896	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575897	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9575898	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
active	9575899	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
active	9575900	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
active	9575901	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
active	9575902	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9575903	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575904	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575905	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575906	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575907	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575908	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575909	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575910	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575911	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9575912	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575913	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575914	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575915	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9575916	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575917	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575918	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575919	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575920	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575921	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575922	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575923	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575924	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9575925	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9575926	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9575927	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575928	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575929	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
inactive	9575930	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575931	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575932	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9575933	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9575934	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575935	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
active	9575936	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9575937	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575938	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575939	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575940	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	125.89	CHEMBL5600	Homo sapiens	pKi		6.9
active	9575941	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9575942	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575943	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575944	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575945	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575946	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575947	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575948	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575949	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575950	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575951	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9575952	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575953	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575954	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575955	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	50.12	CHEMBL5600	Homo sapiens	pKi		7.3
inactive	9575956	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575957	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575958	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9575959	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9575960	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575961	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9575962	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575963	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575964	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575965	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9575966	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	100.0	CHEMBL5600	Homo sapiens	pKi		7.0
active	9575967	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	3.981	CHEMBL5600	Homo sapiens	pKi		8.4
inactive	9575968	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575969	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575970	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575971	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575972	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575973	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9575974	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575975	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575976	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575977	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575978	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	15.85	CHEMBL5600	Homo sapiens	pKi		7.8
inactive	9575979	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575980	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575981	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9575982	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575983	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575984	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCn1c(=C(C#N)C(=O)O)sc(=CNc2ccccc2)c1=O		CHEMBL1986996	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9575985	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575986	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9575987	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575988	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	63.1	CHEMBL5600	Homo sapiens	pKi		7.2
inactive	9575989	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9575990	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575991	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
active	9575992	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
active	9575993	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	=	Ki	nM	1.0	CHEMBL5600	Homo sapiens	pKi		9.0
active	9575994	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9575995	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9575996	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
active	9575997	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9575998	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9575999	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576000	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9576001	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9576002	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9576003	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9576004	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9576005	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576006	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9576007	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9576008	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576009	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576010	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9576011	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9576012	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9576013	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576014	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9576015	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9576016	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9576017	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
inactive	9576018	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576019	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9576020	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	63.1	CHEMBL5600	Homo sapiens	pKi		7.2
active	9576021	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9576022	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576023	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9576024	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576025	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576026	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576027	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576028	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576029	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576030	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576031	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576032	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576033	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576034	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9576035	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9576036	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
active	9576037	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	158.49	CHEMBL5600	Homo sapiens	pKi		6.8
active	9576038	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9579614	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579615	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579616	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9579617	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
active	9579618	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9579619	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579620	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579621	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579622	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9579623	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579624	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9579625	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579626	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9579627	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579628	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579629	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9579630	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579631	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
active	9579632	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9579633	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579634	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
inactive	9579635	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579636	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	251.19	CHEMBL5600	Homo sapiens	pKi		6.6
active	9579637	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	15.85	CHEMBL5600	Homo sapiens	pKi		7.8
inactive	9579638	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579639	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579640	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9579641	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579642	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579643	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Fc1ccc2c(c1)-c1n[nH]cc1CS2		CHEMBL1989069	=	Ki	nM	12589.25	CHEMBL5600	Homo sapiens	pKi		4.9
active	9579644	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579645	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9579646	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579647	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579648	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579649	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9579650	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579651	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9579652	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579653	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579654	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9579655	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579656	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579657	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	7.943	CHEMBL5600	Homo sapiens	pKi		8.1
inactive	9579658	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579659	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579660	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9579661	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579662	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9579663	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579664	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579665	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579666	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579667	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579668	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9579669	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579670	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579671	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579672	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579673	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579674	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579675	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
inactive	9579676	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579677	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579678	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
active	9579679	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9579680	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579681	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579682	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9579683	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579684	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
inactive	9579685	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9579686	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579687	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579688	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579689	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	158.49	CHEMBL5600	Homo sapiens	pKi		6.8
inactive	9579690	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579691	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	39.81	CHEMBL5600	Homo sapiens	pKi		7.4
inactive	9579692	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579693	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579694	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579695	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579696	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9579697	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579698	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	158.49	CHEMBL5600	Homo sapiens	pKi		6.8
inactive	9579699	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579700	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9579701	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2002660	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579702	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9579703	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
active	9579704	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
active	9579705	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
active	9579706	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9579707	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579708	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
active	9579709	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
active	9579710	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9579711	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
inactive	9579712	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579713	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579714	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579715	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
active	9579716	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
active	9579717	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9579718	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9579719	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579720	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	251.19	CHEMBL5600	Homo sapiens	pKi		6.6
active	9579721	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
inactive	9579722	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579723	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579724	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579725	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579726	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579727	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579728	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9579729	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579730	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579731	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
inactive	9579732	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579733	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579734	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579735	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579736	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579737	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9579738	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579739	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579740	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579741	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9579742	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579743	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579744	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579745	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9579746	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579747	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579748	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579749	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579750	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9579751	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579752	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579753	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579754	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579755	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	=	Ki	nM	125.89	CHEMBL5600	Homo sapiens	pKi		6.9
inactive	9579756	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579757	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9579758	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579759	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	125.89	CHEMBL5600	Homo sapiens	pKi		6.9
inactive	9579760	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579761	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579762	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579763	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579764	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579765	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579766	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579767	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	251.19	CHEMBL5600	Homo sapiens	pKi		6.6
active	9579768	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9579769	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
active	9579770	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
inactive	9579771	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579772	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	251.19	CHEMBL5600	Homo sapiens	pKi		6.6
active	9579773	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2c1C(c1ccccc1Br)C(C#N)=C(N)O2		CHEMBL2005214	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9579774	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579775	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579776	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579777	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579778	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579779	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579780	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579781	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579782	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9579783	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579784	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9579785	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579786	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579787	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9579788	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579789	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579790	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9579791	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579792	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9579793	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	39.81	CHEMBL5600	Homo sapiens	pKi		7.4
active	9579794	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	=	Ki	nM	79.43	CHEMBL5600	Homo sapiens	pKi		7.1
inactive	9579795	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579796	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579797	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579798	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	125.89	CHEMBL5600	Homo sapiens	pKi		6.9
inactive	9579799	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579800	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579801	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579802	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579803	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579804	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579805	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579806	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9579807	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579808	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579809	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579810	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	158.49	CHEMBL5600	Homo sapiens	pKi		6.8
active	9579811	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
active	9579812	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	12.59	CHEMBL5600	Homo sapiens	pKi		7.9
active	9579813	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	158.49	CHEMBL5600	Homo sapiens	pKi		6.8
inactive	9579814	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579815	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579816	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579817	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579818	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9579819	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579820	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
inactive	9579821	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579822	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579823	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
inactive	9579824	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579825	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579826	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
active	9579827	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9579828	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579829	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579830	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579831	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9579832	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579833	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9579834	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9579835	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579836	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
active	9579837	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9579838	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
active	9579839	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9579840	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579841	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579842	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579843	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579844	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579845	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579846	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9579847	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9579848	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9579849	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9579850	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	<	Ki	nM	15848.93	CHEMBL5600	Homo sapiens	pKi		4.8
active	9579851	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9579852	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583426	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9583427	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583428	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583429	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583430	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583431	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583432	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583433	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583434	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	31.62	CHEMBL5600	Homo sapiens	pKi		7.5
inactive	9583435	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	15848.93	CHEMBL5600	Homo sapiens	pKi		4.8
inactive	9583436	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583437	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583438	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583439	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9583440	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583441	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583442	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9583443	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583444	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9583445	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583446	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9583447	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9583448	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583449	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	50.12	CHEMBL5600	Homo sapiens	pKi		7.3
active	9583450	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9583451	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583452	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583453	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583454	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583455	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583456	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583457	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
inactive	9583458	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583459	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583460	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583461	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583462	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583463	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
inactive	9583464	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583465	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583466	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583467	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583468	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583469	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9583470	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9583471	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583472	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583473	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583474	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583475	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	50.12	CHEMBL5600	Homo sapiens	pKi		7.3
active	9583476	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9583477	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583478	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583479	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9583480	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9583481	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	79.43	CHEMBL5600	Homo sapiens	pKi		7.1
active	9583482	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9583483	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9583484	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	19.95	CHEMBL5600	Homo sapiens	pKi		7.7
active	9583485	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
active	9583486	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	50.12	CHEMBL5600	Homo sapiens	pKi		7.3
active	9583487	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
inactive	9583488	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583489	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9583490	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583491	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583492	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
active	9583493	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
inactive	9583494	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583495	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583496	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583497	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	125.89	CHEMBL5600	Homo sapiens	pKi		6.9
active	9583498	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	251.19	CHEMBL5600	Homo sapiens	pKi		6.6
inactive	9583499	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583500	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
active	9583501	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
active	9583502	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
active	9583503	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9583504	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583505	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583506	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	794.33	CHEMBL5600	Homo sapiens	pKi		6.1
inactive	9583507	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583508	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	1995.26	CHEMBL5600	Homo sapiens	pKi		5.7
active	9583509	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	1258.93	CHEMBL5600	Homo sapiens	pKi		5.9
inactive	9583510	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583511	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583512	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583513	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	1584.89	CHEMBL5600	Homo sapiens	pKi		5.8
inactive	9583514	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583515	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583516	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583517	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583518	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583519	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583520	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9583521	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583522	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583523	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583524	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583525	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583526	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583527	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583528	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583529	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9583530	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583531	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583532	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583533	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9583534	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583535	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	199.53	CHEMBL5600	Homo sapiens	pKi		6.7
active	9583536	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	630.96	CHEMBL5600	Homo sapiens	pKi		6.2
inactive	9583537	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583538	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	398.11	CHEMBL5600	Homo sapiens	pKi		6.4
active	9583539	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9583540	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583541	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583542	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583543	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9583544	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583545	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583546	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583547	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9583548	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583549	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583550	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583551	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	3981.07	CHEMBL5600	Homo sapiens	pKi		5.4
inactive	9583552	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583553	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583554	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583555	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583556	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583557	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583558	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583559	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9583560	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583561	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9583562	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583563	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583564	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	=	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583565	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583566	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583567	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	501.19	CHEMBL5600	Homo sapiens	pKi		6.3
inactive	9583568	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583569	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
inactive	9583570	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583571	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583572	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583573	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	316.23	CHEMBL5600	Homo sapiens	pKi		6.5
active	9583574	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	5011.87	CHEMBL5600	Homo sapiens	pKi		5.3
inactive	9583575	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
inactive	9583576	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583577	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9583578	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583579	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	6.31	CHEMBL5600	Homo sapiens	pKi		8.2
active	9583580	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1000.0	CHEMBL5600	Homo sapiens	pKi		6.0
inactive	9583581	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	6309.57	CHEMBL5600	Homo sapiens	pKi		5.2
active	9583582	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
inactive	9583583	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	2511.89	CHEMBL5600	Homo sapiens	pKi		5.6
active	9583584	CHEMBL1963756	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MARK3	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	3162.28	CHEMBL5600	Homo sapiens	pKi		5.5
	10839398	CHEMBL2014964	Inhibition of MARK3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	47.0	CHEMBL5600	Homo sapiens	INH	%	47.0
	10839606	CHEMBL2015153	Inhibition of MARK3 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	7.0	CHEMBL5600	Homo sapiens	Activity	%	7.0
	10839685	CHEMBL2016285	Inhibition of MARK3 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	34.0	CHEMBL5600	Homo sapiens	Activity	%	34.0
	12046356	CHEMBL2157283	Inhibition of MARK3 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	5.3	CHEMBL5600	Homo sapiens	INH	%	5.3
	12170785	CHEMBL2209912	Inhibition of MARK3 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	101.0	CHEMBL5600	Homo sapiens	Activity	%	101.0
	12170916	CHEMBL2213912	Inhibition of MARK3 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	98.0	CHEMBL5600	Homo sapiens	Activity	%	98.0
	12172358	CHEMBL2210623	Inhibition of MARK3 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	50.0	CHEMBL5600	Homo sapiens	Activity	%	50.0
	12190850	CHEMBL2213803	Inhibition of MARK3	B	Cn1cc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cn1		CHEMBL2207208	=	IC50	nM	20.0	CHEMBL5600	Homo sapiens	IC50	uM	0.02
	12190851	CHEMBL2213803	Inhibition of MARK3	B	O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C1CC1)C1CCC1		CHEMBL2207198	=	IC50	nM	12.0	CHEMBL5600	Homo sapiens	IC50	uM	0.012
	12195382	CHEMBL2210931	Inhibition of recombinant CTAK1 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	4830.0	CHEMBL5600	Homo sapiens	Ki	nM	4830.0
	12647983	CHEMBL2329199	Inhibition of CTAK1 (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	37.0	CHEMBL5600	Homo sapiens	INH	%	37.0
	12647984	CHEMBL2329199	Inhibition of CTAK1 (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	35.0	CHEMBL5600	Homo sapiens	INH	%	35.0
	12647985	CHEMBL2329199	Inhibition of CTAK1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	-5.0	CHEMBL5600	Homo sapiens	INH	%	-5.0
	12647986	CHEMBL2329199	Inhibition of CTAK1 (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	49.0	CHEMBL5600	Homo sapiens	INH	%	49.0
	12649648	CHEMBL2329549	Inhibition of CTAK1 (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	91.0	CHEMBL5600	Homo sapiens	INH	%	91.0
	12649649	CHEMBL2329549	Inhibition of CTAK1 (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	90.0	CHEMBL5600	Homo sapiens	INH	%	90.0
	12649650	CHEMBL2329549	Inhibition of CTAK1 (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	73.0	CHEMBL5600	Homo sapiens	INH	%	73.0
	12672991	CHEMBL2339722	Inhibition of recombinant MARK3 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	17.0	CHEMBL5600	Homo sapiens	Activity	%	17.0
	12672992	CHEMBL2339722	Inhibition of recombinant MARK3 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	24.0	CHEMBL5600	Homo sapiens	Activity	%	24.0
	12727736	CHEMBL2351170	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	94.0	CHEMBL5600	Homo sapiens	Activity	%	94.0
	12729024	CHEMBL2351930	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	113.0	CHEMBL5600	Homo sapiens	Activity	%	113.0
	12729908	CHEMBL2349812	Inhibition of MARK3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	96.0	CHEMBL5600	Homo sapiens	Activity	%	96.0
	12730167	CHEMBL2351170	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL5600	Homo sapiens	Activity	%	99.0
	13282378	CHEMBL2378451	Inhibition of c-TAK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	25.0	CHEMBL5600	Homo sapiens	INH	%	25.0
	13282379	CHEMBL2378451	Inhibition of c-TAK1 (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	67.0	CHEMBL5600	Homo sapiens	INH	%	67.0
	13282380	CHEMBL2378451	Inhibition of c-TAK1 (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	29.0	CHEMBL5600	Homo sapiens	INH	%	29.0
	13282381	CHEMBL2378451	Inhibition of c-TAK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1	Outside typical range	CHEMBL2376152	=	Inhibition	%	-11.0	CHEMBL5600	Homo sapiens	INH	%	-11.0
	13282382	CHEMBL2378451	Inhibition of c-TAK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1	Outside typical range	CHEMBL2376144	=	Inhibition	%	-24.0	CHEMBL5600	Homo sapiens	INH	%	-24.0
	13282383	CHEMBL2378451	Inhibition of c-TAK1 (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	61.0	CHEMBL5600	Homo sapiens	INH	%	61.0
	13375783	CHEMBL2404179	Inhibition of MARK3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL5600	Homo sapiens	INH	%	3.0
	13439819	CHEMBL2426964	Competitive binding affinity to MARK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	13440852	CHEMBL2429595	Inhibition of MARK3 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-20.0	CHEMBL5600	Homo sapiens	INH	%	-20.0
	13445652	CHEMBL2426964	Competitive binding affinity to MARK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	13451639	CHEMBL2426964	Competitive binding affinity to MARK3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	13453030	CHEMBL2429595	Inhibition of MARK3 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-11.0	CHEMBL5600	Homo sapiens	INH	%	-11.0
	13453078	CHEMBL2429595	Inhibition of MARK3 (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1		CHEMBL2425145	=	Inhibition	%	-6.0	CHEMBL5600	Homo sapiens	INH	%	-6.0
	13465468	CHEMBL2434219	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	84.0	CHEMBL5600	Homo sapiens	Activity	%	84.0
	13465494	CHEMBL2434606	Inhibition of human MARK3 assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	62.0	CHEMBL5600	Homo sapiens	Activity	%	62.0
	13465519	CHEMBL2434194	Inhibition of human MARK3 assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	88.0	CHEMBL5600	Homo sapiens	Activity	%	88.0
	13465542	CHEMBL2434606	Inhibition of human MARK3 assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	82.0	CHEMBL5600	Homo sapiens	Activity	%	82.0
	13466468	CHEMBL2434219	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	94.61	CHEMBL5600	Homo sapiens	Activity	%	94.61
	13466495	CHEMBL2434606	Inhibition of human MARK3 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	79.23	CHEMBL5600	Homo sapiens	Activity	%	79.23
	13466522	CHEMBL2434219	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	62.58	CHEMBL5600	Homo sapiens	Activity	%	62.58
	13466549	CHEMBL2434606	Inhibition of human MARK3 assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	17.89	CHEMBL5600	Homo sapiens	Activity	%	17.89
Active	13488396	CHEMBL2439411	Inhibition of human MARK3 at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	13966033	CHEMBL3136648	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	77.0	CHEMBL5600	Homo sapiens	INH	%	77.0
	13973308	CHEMBL3134905	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	6.0	CHEMBL5600	Homo sapiens	INH	%	6.0
	13974026	CHEMBL3136490	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.5	CHEMBL5600	Homo sapiens	INH	%	0.5
	13974117	CHEMBL3135763	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	30.0	CHEMBL5600	Homo sapiens	INH	%	30.0
	13974208	CHEMBL3134740	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	13974299	CHEMBL3136851	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	86.5	CHEMBL5600	Homo sapiens	INH	%	86.5
	13975037	CHEMBL3135997	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	13975128	CHEMBL3135724	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	13975219	CHEMBL3136377	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	3.0	CHEMBL5600	Homo sapiens	INH	%	3.0
	13975862	CHEMBL3135477	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	3.0	CHEMBL5600	Homo sapiens	INH	%	3.0
	13975955	CHEMBL3137009	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	27.5	CHEMBL5600	Homo sapiens	INH	%	27.5
	13976046	CHEMBL3135402	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	18.0	CHEMBL5600	Homo sapiens	INH	%	18.0
	13976137	CHEMBL3135074	Inhibition of human full length c-TAK1 expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	6.5	CHEMBL5600	Homo sapiens	INH	%	6.5
	14593769	CHEMBL3241185	Inhibition of human MARK3	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	>	IC50	nM	10000.0	CHEMBL5600	Homo sapiens	IC50	uM	10.0
	14648110	CHEMBL3267010	Inhibition of human MARK3 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	14648111	CHEMBL3267010	Inhibition of human MARK3 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	15072444	CHEMBL3380779	Inhibition of MARK3 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	103.0	CHEMBL5600	Homo sapiens	Activity	%	103.0
	15251849	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	40.0	CHEMBL5600	Homo sapiens	Activity	%	40.0
	15251948	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	65.0	CHEMBL5600	Homo sapiens	Activity	%	65.0
	15252050	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	75.0	CHEMBL5600	Homo sapiens	Activity	%	75.0
	15252695	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	94.0	CHEMBL5600	Homo sapiens	Activity	%	94.0
	15252797	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	85.0	CHEMBL5600	Homo sapiens	Activity	%	85.0
	15252899	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	79.0	CHEMBL5600	Homo sapiens	Activity	%	79.0
	15253573	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	73.0	CHEMBL5600	Homo sapiens	Activity	%	73.0
	15253675	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	88.0	CHEMBL5600	Homo sapiens	Activity	%	88.0
	15253777	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	77.0	CHEMBL5600	Homo sapiens	Activity	%	77.0
	15254443	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	47.0	CHEMBL5600	Homo sapiens	Activity	%	47.0
	15254545	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	80.0	CHEMBL5600	Homo sapiens	Activity	%	80.0
	15254647	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	69.0	CHEMBL5600	Homo sapiens	Activity	%	69.0
	15255338	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	83.0	CHEMBL5600	Homo sapiens	Activity	%	83.0
	15255440	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	85.0	CHEMBL5600	Homo sapiens	Activity	%	85.0
	15255543	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	92.0	CHEMBL5600	Homo sapiens	Activity	%	92.0
	15256274	CHEMBL3428232	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	72.0	CHEMBL5600	Homo sapiens	Activity	%	72.0
	15686158	CHEMBL3606886	Inhibition of MARK3 (unknown origin) at 2 uM by radioactive filter-binding assay	B	NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I		CHEMBL3605056	>=	Inhibition	%	80.0	CHEMBL5600	Homo sapiens	INH	%	80.0
	15686194	CHEMBL3606985	Inhibition of MARK3 (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL5600	Homo sapiens	INH	%	80.0
	15755899	CHEMBL3630842	Inhibition of MARK3 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	90.0	CHEMBL5600	Homo sapiens	Activity	%	90.0
	15756924	CHEMBL3631286	Inhibition of MARK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-1.36	CHEMBL5600	Homo sapiens	INH	%	-1.36
	15757799	CHEMBL3631286	Inhibition of MARK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	4.8	CHEMBL5600	Homo sapiens	INH	%	4.8
	15758778	CHEMBL3631286	Inhibition of MARK3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-3.77	CHEMBL5600	Homo sapiens	INH	%	-3.77
	16376445	CHEMBL3734469	Inhibition of recombinant human c-TAK1 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	6.0	CHEMBL5600	Homo sapiens	INH	%	6.0
	16413435	CHEMBL3743709	Inhibition of CTAK1 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL5600	Homo sapiens	IC50	uM	10.0
	16426112	CHEMBL3751283	Inhibition of MARK3 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-5.4	CHEMBL5600	Homo sapiens	INH	%	-5.4
	16431894	CHEMBL3747987	Inhibition of human MARK3 using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5600	Homo sapiens	IC50	uM	10.0
	16451505	CHEMBL3760628	Inhibition of MARK3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	8.4	CHEMBL5600	Homo sapiens	INH	%	8.4
	16485744	CHEMBL3771449	Inhibition of human recombinant MARK3 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	96.0	CHEMBL5600	Homo sapiens	Activity	%	96.0
Not Active	16497476	CHEMBL3776617	Inhibition of human MARK3 (2 to 729 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	16507180	CHEMBL3778996	Inhibition of recombinant MARK3 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
Not Active	16514143	CHEMBL3782191	Inhibition of partial length human MARK3 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	16578395	CHEMBL3802267	Inhibition of full length wild type human MARK3 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	87.0	CHEMBL5600	Homo sapiens	Activity	%	87.0
	16594871	CHEMBL3812447	Inhibition of full length human MARK3 expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	16611977	CHEMBL3815474	Inhibition of human MARK3 (2 to 729 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-59.0	CHEMBL5600	Homo sapiens	Activity	%	-59.0
	16611978	CHEMBL3815474	Inhibition of human MARK3 (2 to 729 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-58.0	CHEMBL5600	Homo sapiens	Activity	%	-58.0
	16611979	CHEMBL3815474	Inhibition of human MARK3 (2 to 729 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-89.0	CHEMBL5600	Homo sapiens	Activity	%	-89.0
	16611980	CHEMBL3815474	Inhibition of human MARK3 (2 to 729 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-95.0	CHEMBL5600	Homo sapiens	Activity	%	-95.0
	16614531	CHEMBL3816729	Inhibition of human MARK3 at 1 uM using [KKKVSRSGLYRSPSMPENLNRPR] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	2.0	CHEMBL5600	Homo sapiens	INH	%	2.0
	16618167	CHEMBL3817264	Inhibition of full length recombinant human GST-tagged MARK3 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	16619685	CHEMBL3820253	Inhibition of recombinant human full length GST-tagged MARK3 expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL5600	Homo sapiens	INH	%	75.0
	16628494	CHEMBL3820306	Inhibition of human recombinant full-length MARK3 expressed in insect Sf21 cells at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL5600	Homo sapiens	INH	%	80.0
	16654138	CHEMBL3829184	Inhibition of human MARK3 (2 to 729 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	41.0	CHEMBL5600	Homo sapiens	Activity	%	41.0
	16804178	CHEMBL3869769	Inhibition of human recombinant full length GST-tagged MARK3 expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	58.0	CHEMBL5600	Homo sapiens	INH	%	58.0
	16837323	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC(C)[C@H](C)N1C(=O)C(C)(C)c2cnc(Nc3ccccc3)nc21		CHEMBL3883412	=	IC50	nM	80.0	CHEMBL5600	Homo sapiens	IC50	nM	80.0
	16837324	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC[C@@H](C)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3883766	=	IC50	nM	738.0	CHEMBL5600	Homo sapiens	IC50	nM	738.0
	16837325	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC[C@H](C)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3884253	=	IC50	nM	117.0	CHEMBL5600	Homo sapiens	IC50	nM	117.0
	16837326	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC(=O)N1CCC(N2C(=O)C(C)(C)c3cnc(Nc4ccccc4)nc32)CC1		CHEMBL3884781	=	IC50	nM	1302.0	CHEMBL5600	Homo sapiens	IC50	nM	1302.0
	16837327	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N(C2CCCC2)c2nc(Nc3ccccc3)ncc21		CHEMBL3883637	=	IC50	nM	226.0	CHEMBL5600	Homo sapiens	IC50	nM	226.0
	16837328	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC(C)N1C(=O)C(C)(C)c2cnc(Nc3ccccc3)nc21		CHEMBL3885175	=	IC50	nM	627.0	CHEMBL5600	Homo sapiens	IC50	nM	627.0
	16837329	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CCN1C(=O)C(C)(C)c2cnc(Nc3ccccc3)nc21		CHEMBL3883539	=	IC50	nM	3000.0	CHEMBL5600	Homo sapiens	IC50	nM	3000.0
	16837330	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CN1C(=O)C(C)(C)c2cnc(Nc3cccc(N4CCNCC4)c3)nc21		CHEMBL3885232	=	IC50	nM	850.0	CHEMBL5600	Homo sapiens	IC50	nM	850.0
	16837331	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)Nc2nc(Nc3ccccc3)ncc21		CHEMBL3885486	=	IC50	nM	12770.0	CHEMBL5600	Homo sapiens	IC50	nM	12770.0
	16837332	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	Cn1cc(N2C(=O)C(C)(C)c3cnc(Nc4ccccc4)nc32)cn1		CHEMBL3883997	=	IC50	nM	4300.0	CHEMBL5600	Homo sapiens	IC50	nM	4300.0
	16837333	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N(c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL3883398	=	IC50	nM	2800.0	CHEMBL5600	Homo sapiens	IC50	nM	2800.0
	16837334	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N(C2CCCCC2)c2nc(Nc3cccnc3)ncc21		CHEMBL3883548	=	IC50	nM	346.0	CHEMBL5600	Homo sapiens	IC50	nM	346.0
	16837335	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N(C2CCCCC2)c2nc(Nc3cccc(N4CCNCC4)c3)ncc21		CHEMBL3884535	=	IC50	nM	14.0	CHEMBL5600	Homo sapiens	IC50	nM	14.0
	16837336	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)CN(C2CCCCC2)c2nc(Nc3ccccc3)ncc21		CHEMBL3884098	>	IC50	nM	30000.0	CHEMBL5600	Homo sapiens	IC50	nM	30000.0
	16837337	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	Cn1cc(N2C(=O)c3nc(Nc4ccccc4)ncc3C2(C)C)cn1		CHEMBL3883776	>	IC50	nM	30000.0	CHEMBL5600	Homo sapiens	IC50	nM	30000.0
	16837338	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N(C2CCCCC2)c2nc(Nc3ccccc3)ncc21		CHEMBL3883802	=	IC50	nM	304.0	CHEMBL5600	Homo sapiens	IC50	nM	304.0
	16837339	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	C[C@@H](c1ccccc1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3884884	=	IC50	nM	37.0	CHEMBL5600	Homo sapiens	IC50	nM	37.0
	16837340	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N(C(C)(C)c2ccccc2)c2nc(Nc3cccnc3)ncc21		CHEMBL3884929	=	IC50	nM	1644.0	CHEMBL5600	Homo sapiens	IC50	nM	1644.0
	16837341	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N([C@H](c2ccccc2)C(F)F)c2nc(Nc3ccccc3)ncc21		CHEMBL3885257	=	IC50	nM	2564.0	CHEMBL5600	Homo sapiens	IC50	nM	2564.0
	16837342	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	C[C@@H](c1ccc(F)cc1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3884179	=	IC50	nM	62.0	CHEMBL5600	Homo sapiens	IC50	nM	62.0
	16837343	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N([C@H]2CCc3ccccc32)c2nc(Nc3cccnc3)ncc21		CHEMBL3883433	=	IC50	nM	27.0	CHEMBL5600	Homo sapiens	IC50	nM	27.0
	16837344	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	C[C@@H](c1cccc(O)c1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3884318	=	IC50	nM	10.0	CHEMBL5600	Homo sapiens	IC50	nM	10.0
	16837345	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	1.2	CHEMBL5600	Homo sapiens	IC50	nM	1.2
	16837346	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N([C@H]2CCc3c(N)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3883979	=	IC50	nM	10.0	CHEMBL5600	Homo sapiens	IC50	nM	10.0
	16837347	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	CC1(C)C(=O)N([C@H]2CCc3c(NS(C)(=O)=O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884344	=	IC50	nM	19.0	CHEMBL5600	Homo sapiens	IC50	nM	19.0
	16837348	CHEMBL3876023	Inhibition of full length human MARK3 using biotin labeled peptide substrate by HTRF based assay	B	C[C@H](c1cccc(O)c1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3884080	=	IC50	nM	1800.0	CHEMBL5600	Homo sapiens	IC50	uM	1.8
	16838926	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC(=O)N1CCC(N2C(=O)C(C)(C)c3cnc(Nc4ccccc4)nc32)CC1		CHEMBL3884781	=	IC50	nM	1300.0	CHEMBL5600	Homo sapiens	IC50	uM	1.3
	16838927	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC(=O)N1CCC(N2C(=O)C(C)(C)c3cnc(Nc4ccc(F)cc4)nc32)CC1		CHEMBL3884017	=	IC50	nM	2800.0	CHEMBL5600	Homo sapiens	IC50	uM	2.8
	16838928	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC(=O)N1CCC(N2C(=O)C(C)(C)c3cnc(Nc4cccnc4)nc32)CC1		CHEMBL3884277	=	IC50	nM	2100.0	CHEMBL5600	Homo sapiens	IC50	uM	2.1
	16838929	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC1(C)C(=O)N(C2CCCCC2)c2nc(Nc3cccnc3)ncc21		CHEMBL3883548	=	IC50	nM	346.0	CHEMBL5600	Homo sapiens	IC50	nM	346.0
	16838930	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	C[C@@H](c1ccc(F)cc1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3884179	=	IC50	nM	61.0	CHEMBL5600	Homo sapiens	IC50	nM	61.0
	16838931	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC[C@H](C)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3884253	=	IC50	nM	82.0	CHEMBL5600	Homo sapiens	IC50	nM	82.0
	16838932	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC[C@H](C)N1C(=O)C(C)(C)c2cnc(Nc3ccc(S(C)(=O)=O)cc3)nc21		CHEMBL3885363	=	IC50	nM	120.0	CHEMBL5600	Homo sapiens	IC50	nM	120.0
	16838933	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC[C@H](C)N1C(=O)C(C)(C)c2cnc(Nc3ccc(-c4nnc(C)[nH]4)cc3)nc21		CHEMBL3884116	=	IC50	nM	80.0	CHEMBL5600	Homo sapiens	IC50	nM	80.0
	16838934	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC[C@H](C)N1C(=O)C2(CC2)c2cnc(Nc3cccnc3)nc21		CHEMBL3885080	=	IC50	nM	60.0	CHEMBL5600	Homo sapiens	IC50	nM	60.0
	16838935	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	C[C@H](c1ccc(F)cc1)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3885321	=	IC50	nM	1524.0	CHEMBL5600	Homo sapiens	IC50	nM	1524.0
	16838936	CHEMBL3876478	Inhibition of MARK3 (unknown origin)	B	CC[C@@H](C)N1C(=O)C(C)(C)c2cnc(Nc3cccnc3)nc21		CHEMBL3883766	=	IC50	nM	738.0	CHEMBL5600	Homo sapiens	IC50	nM	738.0
226310	17614747	CHEMBL3705161	Homogenous Time-Resolved Fluorescence (HTRF) Assay: MARK3 activity was assayed in vitro using a Cdc25C biotinylated peptide substrate (Cell Signalling Technologies). The phosphopeptide product was quantitated using a Homogenous Time-Resolved Fluorescence (HTRF) assay system (Park et al., 1999, Anal. Biochem. 269:94-104).	B	N[C@H]1CCCC(F)(F)C1NC(=O)c1nc(-c2cnc3ccccn23)c(Cl)s1		CHEMBL3648446	=	IC50	nM	720.0	CHEMBL5600	Homo sapiens	IC50	nM	720.0
226311	17614748	CHEMBL3705161	Homogenous Time-Resolved Fluorescence (HTRF) Assay: MARK3 activity was assayed in vitro using a Cdc25C biotinylated peptide substrate (Cell Signalling Technologies). The phosphopeptide product was quantitated using a Homogenous Time-Resolved Fluorescence (HTRF) assay system (Park et al., 1999, Anal. Biochem. 269:94-104).	B	Cc1sc(C(=O)NC2[C@H](N)CCCC2(F)F)cc1-c1cnc2cccnn12		CHEMBL3648447	=	IC50	nM	20.0	CHEMBL5600	Homo sapiens	IC50	nM	20.0
226312	17614749	CHEMBL3705161	Homogenous Time-Resolved Fluorescence (HTRF) Assay: MARK3 activity was assayed in vitro using a Cdc25C biotinylated peptide substrate (Cell Signalling Technologies). The phosphopeptide product was quantitated using a Homogenous Time-Resolved Fluorescence (HTRF) assay system (Park et al., 1999, Anal. Biochem. 269:94-104).	B	N[C@@H]1CCCC(F)(F)C1NC(=O)c1cc(-c2cnc3cc(-c4ccc(F)cc4)cnn23)cs1		CHEMBL3648448	=	IC50	nM	0.5	CHEMBL5600	Homo sapiens	IC50	nM	0.5
226313	17614750	CHEMBL3705161	Homogenous Time-Resolved Fluorescence (HTRF) Assay: MARK3 activity was assayed in vitro using a Cdc25C biotinylated peptide substrate (Cell Signalling Technologies). The phosphopeptide product was quantitated using a Homogenous Time-Resolved Fluorescence (HTRF) assay system (Park et al., 1999, Anal. Biochem. 269:94-104).	B	N[C@H]1CCCC(F)(F)C1NC(=O)c1cc(-c2cnc3cccnn23)cs1		CHEMBL3648449	=	IC50	nM	15.0	CHEMBL5600	Homo sapiens	IC50	nM	15.0
226314	17614751	CHEMBL3705161	Homogenous Time-Resolved Fluorescence (HTRF) Assay: MARK3 activity was assayed in vitro using a Cdc25C biotinylated peptide substrate (Cell Signalling Technologies). The phosphopeptide product was quantitated using a Homogenous Time-Resolved Fluorescence (HTRF) assay system (Park et al., 1999, Anal. Biochem. 269:94-104).	B	CCc1sc(C(=O)NC2[C@H](N)CCCC2(F)F)cc1-c1cnc2cc(C)cnn12		CHEMBL3648450	=	IC50	nM	140.0	CHEMBL5600	Homo sapiens	IC50	nM	140.0
Inactive	17917450	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917451	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917452	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917453	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917454	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917455	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917456	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917457	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917458	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917459	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917460	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917461	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	361.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	361.0
Inactive	17917462	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917463	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917464	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917465	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917466	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917467	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917468	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	10397.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	10397.0
Active	17917469	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	321.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	321.0
Active	17917470	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	1609.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	1609.0
Active	17917471	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	105.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	105.0
Inactive	17917472	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917473	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917474	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917475	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917476	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917477	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917478	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917479	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	417.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	417.0
Inactive	17917480	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917481	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917482	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917483	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917484	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	562.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	562.0
Active	17917485	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	10782.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	10782.0
Inactive	17917486	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917487	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917488	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917489	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	133.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	133.0
Inactive	17917490	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917491	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917492	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917493	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917494	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917495	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917496	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917497	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	26617.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	26617.0
Inactive	17917498	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917499	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917500	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917501	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917502	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917503	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917504	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917505	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917506	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917507	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917508	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917509	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917510	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917511	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917512	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917513	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917514	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917515	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917516	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917517	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917518	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917519	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	38457.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	38457.0
Inactive	17917520	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917521	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917522	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917523	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	220.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	220.0
Inactive	17917524	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917525	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917526	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917527	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1370.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	1370.0
Inactive	17917528	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917529	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917530	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917531	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917532	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917533	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	104.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	104.0
Inactive	17917534	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917535	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917536	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917537	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	4490.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	4490.0
Inactive	17917538	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917539	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917540	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917541	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917542	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917543	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917544	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917545	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917546	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1090.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	1090.0
Inactive	17917547	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917548	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917549	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917550	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917551	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917552	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1701.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	1701.0
Inactive	17917553	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917554	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917555	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917556	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917557	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917558	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917559	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917560	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917561	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	2314.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	2314.0
Active	17917562	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	103.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	103.0
Inactive	17917563	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917564	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917565	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	3443.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	3443.0
Inactive	17917566	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917567	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917568	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	9024.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	9024.0
Inactive	17917569	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917570	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917571	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917572	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917573	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917574	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917575	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917576	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917577	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917578	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1520.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	1520.0
Inactive	17917579	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917580	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917581	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917582	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917583	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917584	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917585	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917586	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917587	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	384.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	384.0
Active	17917588	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	1581.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	1581.0
Inactive	17917589	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917590	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	16.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	16.0
Inactive	17917591	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917592	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917593	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917594	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917595	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917596	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917597	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2567.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	2567.0
Inactive	17917598	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917599	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917600	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917601	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917602	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917603	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917604	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917605	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917606	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917607	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917608	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917609	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917610	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917611	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	364.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	364.0
Inactive	17917612	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917613	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917614	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917615	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917616	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	14828.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	14828.0
Inactive	17917617	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917618	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917619	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917620	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917621	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917622	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917623	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917624	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917625	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	2416.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	2416.0
Inactive	17917626	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917627	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917628	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	1932.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	1932.0
Inactive	17917629	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917630	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	204.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	204.0
Inactive	17917631	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917632	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917633	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917634	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917635	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917636	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917637	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917638	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917639	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917640	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917641	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917642	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917643	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917644	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	=	Kd	nM	58240.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	58240.0
Inactive	17917645	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917646	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917647	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917648	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917649	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917650	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917651	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917652	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917653	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917654	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917655	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917656	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917657	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917658	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917659	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917660	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917661	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917662	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917663	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917664	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917665	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917666	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917667	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917668	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917669	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917670	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917671	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917672	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917673	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917674	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917675	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917676	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917677	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917678	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917679	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917680	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917681	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917682	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917683	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917684	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17917685	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	2087.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	2087.0
Active	17917686	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	387.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	387.0
Inactive	17917687	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917688	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917689	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917690	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17917691	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	30000.0
Active	17917692	CHEMBL3991782	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	306.0	CHEMBL5600	Homo sapiens	Kd apparent	nM	306.0
	17964921	CHEMBL3995030	Inhibition of full length human MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	41.0	CHEMBL5600	Homo sapiens	Activity	%	41.0
	18114264	CHEMBL4025230	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	18153011	CHEMBL4034535	Inhibition of MARK3 (unknown origin) labeling at conserved Lysine1 (EVAIKIIDK) at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-8.5	CHEMBL5600	Homo sapiens	INH	%	-8.5
	18153072	CHEMBL4034393	Inhibition of MARK3 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	1.2	CHEMBL5600	Homo sapiens	INH	%	1.2
	18153197	CHEMBL4034534	Inhibition of MARK3 (unknown origin) labeling at conserved Lysine2 at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-10.1	CHEMBL5600	Homo sapiens	INH	%	-10.1
	18203754	CHEMBL4044041	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	99.0	CHEMBL5600	Homo sapiens	Activity	%	99.0
	18211557	CHEMBL4045756	Inhibition of MARK3 conserved Lys1 (EVAIKIIDK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-23.4	CHEMBL5600	Homo sapiens	INH	%	-23.4
	18211558	CHEMBL4045755	Inhibition of MARK3 conserved Lys1 (EVAIKIIDKTQLNPTSLQK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-23.4	CHEMBL5600	Homo sapiens	INH	%	-23.4
	18211559	CHEMBL4045754	Inhibition of MARK3 conserved Lys2 (DLKAENLLLDADMNIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	28.8	CHEMBL5600	Homo sapiens	INH	%	28.8
	18211899	CHEMBL4045995	Inhibition of MARK3 conserved Lys2 (DLKAENLLLDADMNIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-40.6	CHEMBL5600	Homo sapiens	INH	%	-40.6
	18211900	CHEMBL4045996	Inhibition of MARK3 conserved Lys1 (EVAIKIIDKTQLNPTSLQK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-26.3	CHEMBL5600	Homo sapiens	INH	%	-26.3
	18211901	CHEMBL4045997	Inhibition of MARK3 conserved Lys1 (EVAIKIIDK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-6.7	CHEMBL5600	Homo sapiens	INH	%	-6.7
	18232159	CHEMBL4050347	Inhibition of human MARK3 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	84.0	CHEMBL5600	Homo sapiens	Activity	%	84.0
	18253395	CHEMBL4054981	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	68.0	CHEMBL5600	Homo sapiens	Activity	%	68.0
	18253396	CHEMBL4054981	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	18275076	CHEMBL4118404	Inhibition of MARK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAENLLLDADMNIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-7.2	CHEMBL5600	Homo sapiens	INH	%	-7.2
	18275077	CHEMBL4118404	Inhibition of MARK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAENLLLDADMNIK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-8.4	CHEMBL5600	Homo sapiens	INH	%	-8.4
	18275078	CHEMBL4118404	Inhibition of MARK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKAENLLLDADMNIK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	3.6	CHEMBL5600	Homo sapiens	INH	%	3.6
	18275079	CHEMBL4118405	Inhibition of MARK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAIKIIDKTQLNPTSLQK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	8.6	CHEMBL5600	Homo sapiens	INH	%	8.6
	18275080	CHEMBL4118405	Inhibition of MARK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAIKIIDKTQLNPTSLQK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-12.9	CHEMBL5600	Homo sapiens	INH	%	-12.9
	18275081	CHEMBL4118405	Inhibition of MARK3 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled EVAIKIIDKTQLNPTSLQK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-42.6	CHEMBL5600	Homo sapiens	INH	%	-42.6
	18282162	CHEMBL4120117	Inhibition of recombinant full length GST-tagged human MARK3 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	16.8	CHEMBL5600	Homo sapiens	INH	%	16.8
	18282481	CHEMBL4120117	Inhibition of recombinant full length GST-tagged human MARK3 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	14.1	CHEMBL5600	Homo sapiens	INH	%	14.1
	18440296	CHEMBL4157120	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	18443299	CHEMBL4157931	Inhibition of human MARK3 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	99.0	CHEMBL5600	Homo sapiens	Activity	%	99.0
	18449818	CHEMBL4178055	Inhibition of human MARK3 (2 to 729 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	121.0	CHEMBL5600	Homo sapiens	Activity	%	121.0
	18462178	CHEMBL4180865	Inhibition of recombinant human full length His6-tagged MARK3 expressed in Sf21 insect cells assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	91.0	CHEMBL5600	Homo sapiens	Activity	%	91.0
	18484252	CHEMBL4185899	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	80.0	CHEMBL5600	Homo sapiens	Activity	%	80.0
	18484736	CHEMBL4185899	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	95.0	CHEMBL5600	Homo sapiens	Activity	%	95.0
	18489532	CHEMBL4187273	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	81.0	CHEMBL5600	Homo sapiens	Activity	%	81.0
	18507720	CHEMBL4191042	Inhibition of recombinant full-length human MARK3 at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	4.0	CHEMBL5600	Homo sapiens	INH	%	4.0
	18653531	CHEMBL4230138	Inhibition of MARK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-1.0	CHEMBL5600	Homo sapiens	INH	%	-1.0
	18653532	CHEMBL4230138	Inhibition of MARK3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	1.0	CHEMBL5600	Homo sapiens	INH	%	1.0
	18655436	CHEMBL4230799	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	80.0	CHEMBL5600	Homo sapiens	Activity	%	80.0
	18663928	CHEMBL4232912	Inhibition of full length human MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	94.0	CHEMBL5600	Homo sapiens	Activity	%	94.0
	18664025	CHEMBL4233009	Binding affinity to full length human MARK3 (M1 to L729 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL5600	Homo sapiens	Kd	uM	5.0
	18674565	CHEMBL4235322	Inhibition of cTak1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	5000.0	CHEMBL5600	Homo sapiens	Ki	nM	5000.0
	18674566	CHEMBL4235322	Inhibition of cTak1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL5600	Homo sapiens	Ki	nM	2000.0
Not Determined	18674567	CHEMBL4235322	Inhibition of cTak1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL5600	Homo sapiens	Ki		
	18697657	CHEMBL4254330	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	90.0	CHEMBL5600	Homo sapiens	Activity	%	90.0
	18751038	CHEMBL4263856	Inhibition of MARK3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	9.0	CHEMBL5600	Homo sapiens	INH	%	9.0
	18752009	CHEMBL4264388	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	18764536	CHEMBL4267081	Inhibition of human MARK3 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL5600	Homo sapiens	INH	%	70.0
	18764537	CHEMBL4267081	Inhibition of human MARK3 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL5600	Homo sapiens	INH	%	70.0
	18764538	CHEMBL4267081	Inhibition of human MARK3 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL5600	Homo sapiens	INH	%	70.0
	18782847	CHEMBL4270713	Inhibition of MARK3 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL5600	Homo sapiens	Activity	%	80.0
Not Active	18847299	CHEMBL4304921	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	18858052	CHEMBL4307898	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	78.0	CHEMBL5600	Homo sapiens	Activity	%	78.0
	18892649	CHEMBL4314600	Inhibition of recombinant full-length human MARK3 assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	90.0	CHEMBL5600	Homo sapiens	Activity	%	90.0
	18919555	CHEMBL4322911	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MARK3 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	13.0	CHEMBL5600	Homo sapiens	Kd	nM	13.0
	18919743	CHEMBL4322911	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MARK3 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	6.0	CHEMBL5600	Homo sapiens	Kd	nM	6.0
	18938061	CHEMBL4327757	Inhibition of human MARK3 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	148.22	CHEMBL5600	Homo sapiens	Activity	%	148.22
	18938062	CHEMBL4327757	Inhibition of human MARK3 assessed as residual activity at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	111.09	CHEMBL5600	Homo sapiens	Activity	%	111.09
	18938602	CHEMBL4328121	Inhibition of human MARK3 assessed as residual activity at 100 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5600	Homo sapiens	Activity	%	65.0
	18938982	CHEMBL4328485	Inhibition of human MARK3 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.438	CHEMBL5600	Homo sapiens	IC50	10'-10M	4.38
	18953687	CHEMBL4331930	Inhibition of MARK3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	34.0	CHEMBL5600	Homo sapiens	INH	%	34.0
	18953753	CHEMBL4331930	Inhibition of MARK3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	46.0	CHEMBL5600	Homo sapiens	INH	%	46.0
	18953844	CHEMBL4331930	Inhibition of MARK3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	46.0	CHEMBL5600	Homo sapiens	INH	%	46.0
	18953936	CHEMBL4331989	Inhibition of MARK3 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	18.0	CHEMBL5600	Homo sapiens	INH	%	18.0
	18954000	CHEMBL4331989	Inhibition of MARK3 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	18954067	CHEMBL4331930	Inhibition of MARK3 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	36.0	CHEMBL5600	Homo sapiens	INH	%	36.0
	18958963	CHEMBL4333485	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	78.0	CHEMBL5600	Homo sapiens	Activity	%	78.0
	18964437	CHEMBL4335157	Inhibition of recombinant full length human MARK3 assessed as residual activity at 1 uM using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	18964438	CHEMBL4335157	Inhibition of recombinant full length human MARK3 assessed as residual activity at 1 uM using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	99.0	CHEMBL5600	Homo sapiens	Activity	%	99.0
	18971974	CHEMBL4336984	Inhibition of recombinant full length human MARK3 assessed as residual activity at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	91.0	CHEMBL5600	Homo sapiens	Activity	%	91.0
Not Active	19039707	CHEMBL4351935	Inhibition of recombinant full-length human MARK3 at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
Active	19041172	CHEMBL4352433	Inhibition of human MARK3 at 10 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	19059676	CHEMBL4357977	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	90.0	CHEMBL5600	Homo sapiens	Activity	%	90.0
	19090241	CHEMBL4365815	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	19091994	CHEMBL4366468	Inhibition of human MARK3 at 100 nM using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.27	CHEMBL5600	Homo sapiens	INH	%	-2.27
	19114479	CHEMBL4371441	Binding affinity to MARK3 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	3854.0	CHEMBL5600	Homo sapiens	Kd(free)	uM	3.854
	19114710	CHEMBL4371441	Binding affinity to MARK3 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	5622.0	CHEMBL5600	Homo sapiens	Kd(free)	uM	5.622
	19144886	CHEMBL4377902	Inhibition of recombinant full-length human MARK3 at 1 uM using KKKVSRSGLYRSPSMPENLNRPR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	43.0	CHEMBL5600	Homo sapiens	INH	%	43.0
	19147922	CHEMBL4379396	Inhibition of recombinant full length human MARK3 using KKKVSRSGLYRSP as substrate incubated for 40 mins in presence of [gamma-33ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5600	Homo sapiens	IC50	uM	10.0
	19159504	CHEMBL4382608	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	33.0	CHEMBL5600	Homo sapiens	Activity	%	33.0
	19181076	CHEMBL4387287	Inhibition of recombinant full length human GST-tagged MARK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-25 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	16.0	CHEMBL5600	Homo sapiens	INH	%	16.0
	19181302	CHEMBL4387287	Inhibition of recombinant full length human GST-tagged MARK3 expressed in baculovirus expression system at 0.1 uM using serine/threonine-25 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	15.0	CHEMBL5600	Homo sapiens	INH	%	15.0
	19190398	CHEMBL4388820	Inhibition of human full-length recombinant MARK3 expressed in insect cells at 10 uM using CHKtide as substrate preincubated for 15 mins followed by substrate addition and measured after 30 mins in presence of [gamma32P]ATP by scintillation counting analysis relative to control	B	COc1ccc(F)c(-c2ccc(COc3cccc([C@@H](CC(=O)O)C4CC4)c3)cc2C2=CCCC2(C)C)c1		CHEMBL2152070	=	Inhibition	%	81.0	CHEMBL5600	Homo sapiens	INH	%	81.0
	19191503	CHEMBL4389327	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5600	Homo sapiens	INH	%	100.0
	19191990	CHEMBL4389804	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5600	Homo sapiens	INH	%	100.0
	19200246	CHEMBL4391430	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	91.0	CHEMBL5600	Homo sapiens	Activity	%	91.0
	19266491	CHEMBL4405441	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	19292318	CHEMBL4411569	Inhibition of N-terminal GST tagged full length human MARK3 (1 to 729 end residues) expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	50.0	CHEMBL5600	Homo sapiens	INH	%	50.0
	19476465	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cnc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)c1		CHEMBL4547786	=	IC50	nM	13.0	CHEMBL5600	Homo sapiens	IC50	nM	13.0
	19476466	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4cn[nH]c4)cnc23)cs1		CHEMBL4514812	=	IC50	nM	99.0	CHEMBL5600	Homo sapiens	IC50	nM	99.0
	19476467	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4cccnc4)cnc23)cs1		CHEMBL4550262	=	IC50	nM	70.0	CHEMBL5600	Homo sapiens	IC50	nM	70.0
	19476468	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1ccc2ccc(-c3cnc4c(-c5csc(C(=O)NCC(F)(F)F)c5)cnn4c3)cc21		CHEMBL4541288	=	IC50	nM	74.0	CHEMBL5600	Homo sapiens	IC50	nM	74.0
	19476469	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc5ccoc5c4)cnc23)cs1		CHEMBL4526375	=	IC50	nM	38.0	CHEMBL5600	Homo sapiens	IC50	nM	38.0
	19476470	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc5c(c4)OCC5)cnc23)cs1		CHEMBL4557345	=	IC50	nM	15.0	CHEMBL5600	Homo sapiens	IC50	nM	15.0
	19476471	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	COCCOc1ccc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cc1		CHEMBL4593028	=	IC50	nM	5.0	CHEMBL5600	Homo sapiens	IC50	nM	5.0
	19476482	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	<=	IC50	nM	0.5	CHEMBL5600	Homo sapiens	IC50	nM	0.5
	19476483	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@H]5N)c4)cnn3c2)cn1		CHEMBL4532781	=	IC50	nM	1.0	CHEMBL5600	Homo sapiens	IC50	nM	1.0
	19476484	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4528550	=	IC50	nM	2.0	CHEMBL5600	Homo sapiens	IC50	nM	2.0
	19476485	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCC[C@H]5N)c4)cnn3c2)cn1		CHEMBL4562217	=	IC50	nM	3.0	CHEMBL5600	Homo sapiens	IC50	nM	3.0
	19476486	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5O)c4)cnn3c2)cn1		CHEMBL4579339	=	IC50	nM	9.0	CHEMBL5600	Homo sapiens	IC50	nM	9.0
	19476487	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@H]5O)c4)cnn3c2)cn1		CHEMBL4544609	=	IC50	nM	24.0	CHEMBL5600	Homo sapiens	IC50	nM	24.0
	19476488	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCC[C@@H]5O)c4)cnn3c2)cn1		CHEMBL4588200	=	IC50	nM	43.0	CHEMBL5600	Homo sapiens	IC50	nM	43.0
	19476489	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCC[C@H]5O)c4)cnn3c2)cn1		CHEMBL4543195	=	IC50	nM	10.0	CHEMBL5600	Homo sapiens	IC50	nM	10.0
	19476490	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NC(CO)C5CC5)c4)cnn3c2)cn1		CHEMBL4571737	=	IC50	nM	9.0	CHEMBL5600	Homo sapiens	IC50	nM	9.0
	19476491	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	CCNC(=O)c1cc(-c2cnn3cc(-c4cnn(C)c4)cnc23)cs1		CHEMBL4556844	=	IC50	nM	129.0	CHEMBL5600	Homo sapiens	IC50	nM	129.0
	19476497	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCCC(N)C(F)(F)F)c4)cnn3c2)cn1		CHEMBL4569165	=	IC50	nM	10.0	CHEMBL5600	Homo sapiens	IC50	nM	10.0
	19476498	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCCC(N)C(F)F)c4)cnn3c2)cn1		CHEMBL4578265	=	IC50	nM	15.0	CHEMBL5600	Homo sapiens	IC50	nM	15.0
	19476499	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCCC(N)CF)c4)cnn3c2)cn1		CHEMBL4589674	=	IC50	nM	22.0	CHEMBL5600	Homo sapiens	IC50	nM	22.0
	19476514	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	6.0	CHEMBL5600	Homo sapiens	IC50	nM	6.0
	19476519	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	1.0	CHEMBL5600	Homo sapiens	IC50	nM	1.0
	19476520	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cc1sc(C(=O)N[C@@H]2CCCC[C@@H]2N)cc1-c1cnn2cc(-c3cnn(C)c3)cnc12		CHEMBL4550486	=	IC50	nM	1.3	CHEMBL5600	Homo sapiens	IC50	nM	1.3
	19476521	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cc1sc(C(=O)N[C@H]2CCCC(F)(F)[C@H]2N)cc1-c1cnn2cc(-c3cnn(C)c3)cnc12		CHEMBL4561857	=	IC50	nM	130.0	CHEMBL5600	Homo sapiens	IC50	nM	130.0
	19476522	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(-c3cnn(C)c3)cnc12		CHEMBL4565845	<	IC50	nM	0.25	CHEMBL5600	Homo sapiens	IC50	nM	0.25
	19476523	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cccnc12		CHEMBL4552799	=	IC50	nM	2.4	CHEMBL5600	Homo sapiens	IC50	nM	2.4
	19476524	CHEMBL4479676	Inhibition of full-length recombinant human GST-tagged MARK3 expressed in baculovirus expression system using biotinylated-Cdc25C peptide substrate measured after 2 hrs by HTRF assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	5.0	CHEMBL5600	Homo sapiens	IC50	nM	5.0
	20600326	CHEMBL4603423	Inhibition of recombinant full-length human MARK3 expressed in insect cells at 10 uM using CHKtide as substrate after 30 mins by radiometric scintillation analysis relative to control	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C	Outside typical range	CHEMBL4634634	=	Inhibition	%	-25.0	CHEMBL5600	Homo sapiens	INH	%	-25.0
	20600589	CHEMBL4603541	Inhibition of recombinant full length human GST-tagged MARK3 expressed in baculovirus expression system using serine/threonine-25 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5600	Homo sapiens	IC50	uM	100.0
	22392096	CHEMBL4667191	Inhibition of recombinant human GST-tagged full length MARK3 expressed in baculovirus expression system using Ser/Thr 25 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-3.5	CHEMBL5600	Homo sapiens	INH	%	-3.5
	22423483	CHEMBL4674317	Inhibition of human MARK3 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	70.88	CHEMBL5600	Homo sapiens	Activity	%	70.88
	22423484	CHEMBL4674317	Inhibition of human MARK3 using KKKVSRSGLYRSPSMPENLNRPR as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	2.72	CHEMBL5600	Homo sapiens	Activity	%	2.72
	22843683	CHEMBL4720669	Inhibition of human MARK3 using KKKVSRSGLYRSPSMPENLNRPR as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.297	CHEMBL5600	Homo sapiens	IC50	10^-10M	2.97
	22844031	CHEMBL4721017	Inhibition of human MARK3 assessed as residual activity using KKKVSRSGLYRSPSMPENLNRPR as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	100.4	CHEMBL5600	Homo sapiens	Activity	%	100.4
	22844783	CHEMBL4721458	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	92.39	CHEMBL5600	Homo sapiens	Activity	%	92.39
Not Active	22889529	CHEMBL4729048	Inhibition of wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL5600	Homo sapiens	INH		
	22948891	CHEMBL4765708	Inhibition of human MARK3 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	22948892	CHEMBL4765708	Inhibition of human MARK3 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	103.0	CHEMBL5600	Homo sapiens	Activity	%	103.0
	22948893	CHEMBL4765708	Inhibition of human MARK3 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	93.0	CHEMBL5600	Homo sapiens	Activity	%	93.0
	22948894	CHEMBL4765708	Inhibition of human MARK3 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	101.0	CHEMBL5600	Homo sapiens	Activity	%	101.0
	22948895	CHEMBL4765708	Inhibition of human MARK3 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	96.0	CHEMBL5600	Homo sapiens	Activity	%	96.0
	22948896	CHEMBL4765708	Inhibition of human MARK3 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	93.0	CHEMBL5600	Homo sapiens	Activity	%	93.0
	22949252	CHEMBL4765769	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	87.0	CHEMBL5600	Homo sapiens	Activity	%	87.0
	22949253	CHEMBL4765769	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	96.0	CHEMBL5600	Homo sapiens	Activity	%	96.0
	22949254	CHEMBL4765769	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	97.0	CHEMBL5600	Homo sapiens	Activity	%	97.0
	22949255	CHEMBL4765769	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	93.0	CHEMBL5600	Homo sapiens	Activity	%	93.0
	22949256	CHEMBL4765769	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	90.0	CHEMBL5600	Homo sapiens	Activity	%	90.0
	22949257	CHEMBL4765769	Inhibition of human MARK3 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	88.0	CHEMBL5600	Homo sapiens	Activity	%	88.0
	23120662	CHEMBL4804427	Inhibition of MARK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	14800.0	CHEMBL5600	Homo sapiens	IC50	uM	14.8
	23120663	CHEMBL4804427	Inhibition of MARK3 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	14500.0	CHEMBL5600	Homo sapiens	IC50	uM	14.5
	23120664	CHEMBL4804427	Inhibition of MARK3 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	6800.0	CHEMBL5600	Homo sapiens	IC50	uM	6.8
	23120665	CHEMBL4804427	Inhibition of MARK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	4800.0	CHEMBL5600	Homo sapiens	IC50	uM	4.8
	23120666	CHEMBL4804427	Inhibition of MARK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-22700.0	CHEMBL5600	Homo sapiens	IC50	uM	-22.7
	23120667	CHEMBL4804427	Inhibition of MARK3 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	70200.0	CHEMBL5600	Homo sapiens	IC50	uM	70.2
	23121701	CHEMBL4804609	Inhibition of MARK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	35.0	CHEMBL5600	Homo sapiens	INH	%	35.0
	23121702	CHEMBL4804609	Inhibition of MARK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	23121703	CHEMBL4804609	Inhibition of MARK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	23121704	CHEMBL4804609	Inhibition of MARK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	23121705	CHEMBL4804609	Inhibition of MARK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL5600	Homo sapiens	INH	%	0.0
	23121706	CHEMBL4804609	Inhibition of MARK3 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	75.0	CHEMBL5600	Homo sapiens	INH	%	75.0
	23122662	CHEMBL4805013	Inhibition of human MARK3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL5600	Homo sapiens	Activity	%	94.0
	23123357	CHEMBL4805601	Inhibition of human MARK3 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	23123816	CHEMBL4806060	Inhibition of DNA-tagged human MARK3 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	98.0	CHEMBL5600	Homo sapiens	Activity	%	98.0
	23124804	CHEMBL4806618	Inhibition of human MARK3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL5600	Homo sapiens	Activity	%	98.0
	23124805	CHEMBL4806618	Inhibition of human MARK3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5600	Homo sapiens	Activity	%	100.0
	23128278	CHEMBL4807901	Inhibition of MARK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5600	Homo sapiens	Activity	%	75.0
	23128279	CHEMBL4807901	Inhibition of MARK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5600	Homo sapiens	Activity	%	75.0
	23128280	CHEMBL4807901	Inhibition of MARK3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5600	Homo sapiens	Activity	%	75.0
	23195905	CHEMBL4819720	Binding affinity to wild-type human full length MARK3 (M1 to L729 residues) expressed in bacterial expression system by measuring active site-directed competition binding based Kinomescan method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	=	Kd	nM	11.0	CHEMBL5600	Homo sapiens	Kd	nM	11.0
	23195910	CHEMBL4819725	Inhibition of human MARK3 using KKKVSRSGLYRSPSMPENLNRPR as substrate at 100 nM by direct-filter Binding radiometric assay relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	=	Inhibition	%	92.0	CHEMBL5600	Homo sapiens	INH	%	92.0
Not Active	23317497	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	86.0	CHEMBL5600	Homo sapiens	% Control	%	86.0
Not Active	23317965	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23318632	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23319115	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	93.0	CHEMBL5600	Homo sapiens	% Control	%	93.0
Not Active	23319752	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	98.7	CHEMBL5600	Homo sapiens	% Control	%	98.7
Not Active	23320227	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	93.7	CHEMBL5600	Homo sapiens	% Control	%	93.7
Not Active	23320905	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23321373	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	98.0	CHEMBL5600	Homo sapiens	% Control	%	98.0
Not Active	23322003	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23322471	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23323160	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23323628	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	95.0	CHEMBL5600	Homo sapiens	% Control	%	95.0
Not Active	23324482	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23325117	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23325585	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23326232	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23326700	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	92.0	CHEMBL5600	Homo sapiens	% Control	%	92.0
Not Active	23327400	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	89.0	CHEMBL5600	Homo sapiens	% Control	%	89.0
Not Active	23327868	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23328455	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23328923	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23329412	CHEMBL4881119	MARK3(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	100.0	CHEMBL5600	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23329869	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	93.0	CHEMBL5600	Homo sapiens	% Control	%	93.0
Not Active	23330337	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	89.0	CHEMBL5600	Homo sapiens	% Control	%	89.0
Not Active	23331093	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	98.0	CHEMBL5600	Homo sapiens	% Control	%	98.0
Not Active	23331561	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23332148	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	85.1	CHEMBL5600	Homo sapiens	% Control	%	85.1
Not Active	23332614	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23333332	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23333971	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	89.0	CHEMBL5600	Homo sapiens	% Control	%	89.0
Not Active	23334439	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23335418	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	74.0	CHEMBL5600	Homo sapiens	% Control	%	74.0
Not Active	23335886	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	83.0	CHEMBL5600	Homo sapiens	% Control	%	83.0
Not Active	23336513	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23336981	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	95.0	CHEMBL5600	Homo sapiens	% Control	%	95.0
Not Active	23337809	CHEMBL4882180	MARK3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	98.0	CHEMBL5600	Homo sapiens	% Ctrl	%	98.0
Not Active	23338062	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	99.0	CHEMBL5600	Homo sapiens	% Control	%	99.0
Not Active	23338530	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23339142	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23339610	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23340247	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23340715	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	92.0	CHEMBL5600	Homo sapiens	% Control	%	92.0
Not Active	23341372	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	88.0	CHEMBL5600	Homo sapiens	% Control	%	88.0
Not Active	23341840	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23342456	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	96.0	CHEMBL5600	Homo sapiens	% Control	%	96.0
Not Active	23342924	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23343554	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	93.0	CHEMBL5600	Homo sapiens	% Control	%	93.0
Not Active	23344022	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	81.0	CHEMBL5600	Homo sapiens	% Control	%	81.0
Not Active	23344660	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23345233	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	95.0	CHEMBL5600	Homo sapiens	% Control	%	95.0
Not Active	23345701	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23346278	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23346746	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23347348	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23347838	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	89.6	CHEMBL5600	Homo sapiens	% Control	%	89.6
Not Active	23348417	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23348885	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23349472	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	79.0	CHEMBL5600	Homo sapiens	% Control	%	79.0
Not Active	23350090	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23350558	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23351163	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23351631	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23352129	CHEMBL4882818	MARK3 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	1.571	CHEMBL5600	Homo sapiens	% Inhibition	%	1.5713
Not Active	23352273	CHEMBL4882954	Protein Serine/Threonine Kinase, MARK3 Eurofins-Panlabs enzyme assay	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	11.0	CHEMBL5600	Homo sapiens	% inhibition	%	11.0
Not Active	23352655	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	73.0	CHEMBL5600	Homo sapiens	% Control	%	73.0
Not Active	23353123	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23354005	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23354473	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23354825	CHEMBL4882954	Protein Serine/Threonine Kinase, MARK3 Eurofins-Panlabs enzyme assay	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		Inhibition	%	7.0	CHEMBL5600	Homo sapiens	% inhibition	%	7.0
Not Active	23355205	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23355673	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23356309	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23356777	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23357386	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23358033	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	89.0	CHEMBL5600	Homo sapiens	% Control	%	89.0
Not Active	23358501	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23359087	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23359685	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23360153	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	98.0	CHEMBL5600	Homo sapiens	% Control	%	98.0
Active	23360738	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	12.0	CHEMBL5600	Homo sapiens	% Control	%	12.0
Not Active	23361206	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23361779	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23362315	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23362783	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	86.0	CHEMBL5600	Homo sapiens	% Control	%	86.0
Not Active	23364425	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	96.0	CHEMBL5600	Homo sapiens	% Control	%	96.0
Not Active	23364893	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Slightly Active	23365632	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	38.0	CHEMBL5600	Homo sapiens	% Control	%	38.0
Not Active	23366175	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	93.0	CHEMBL5600	Homo sapiens	% Control	%	93.0
Not Active	23366765	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	78.0	CHEMBL5600	Homo sapiens	% Control	%	78.0
Not Active	23367233	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	94.0	CHEMBL5600	Homo sapiens	% Control	%	94.0
Not Active	23367635	CHEMBL4883988	MARK3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	95.0	CHEMBL5600	Homo sapiens	% Residual activity with Skepinone-L	%	95.0
Not Active	23368111	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23368579	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23369178	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23369646	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23370133	CHEMBL4884377	MARK3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	70.0	CHEMBL5600	Homo sapiens	% residual kinase activity	%	70.0
Slightly Active	23370614	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	30.0	CHEMBL5600	Homo sapiens	% Control	%	30.0
Not Active	23371082	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	92.0	CHEMBL5600	Homo sapiens	% Control	%	92.0
Not Active	23371891	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	74.0	CHEMBL5600	Homo sapiens	% Control	%	74.0
Not Active	23372359	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
	23372810	CHEMBL4884775	MARK3(MAR3LGO5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5600	Homo sapiens	pIC50		6.0
	23373219	CHEMBL4885066	MARK3(MAR3LGO5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5600	Homo sapiens	pIC50		6.0
	23373577	CHEMBL4885354	MARK3(MAR3LGO5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5600	Homo sapiens	pIC50		6.0
Not Active	23375029	CHEMBL4886018	MARK3 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	8.5	CHEMBL5600	Homo sapiens	% Inhibition	%	8.5
Not Active	23375786	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23376254	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23376831	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	89.0	CHEMBL5600	Homo sapiens	% Control	%	89.0
Not Active	23377299	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	95.0	CHEMBL5600	Homo sapiens	% Control	%	95.0
Not Active	23378159	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23378627	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23379794	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23380262	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	87.0	CHEMBL5600	Homo sapiens	% Control	%	87.0
Not Active	23380956	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	94.0	CHEMBL5600	Homo sapiens	% Control	%	94.0
Not Active	23381604	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	92.0	CHEMBL5600	Homo sapiens	% Control	%	92.0
Not Active	23382072	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23382696	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	90.0	CHEMBL5600	Homo sapiens	% Control	%	90.0
Not Active	23383164	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	52.0	CHEMBL5600	Homo sapiens	% Control	%	52.0
Not Active	23383634	CHEMBL4887290	MARK3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	90.0	CHEMBL5600	Homo sapiens	% Ctrl	%	90.0
Not Active	23384047	CHEMBL4887645	MARK3 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	63.8	CHEMBL5600	Homo sapiens	% Ctrl	%	63.8
Not Active	23384339	CHEMBL4887934	MARK3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-4.67	CHEMBL5600	Homo sapiens	% inhibition	%	-4.67
Not Active	23385079	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
Not Active	23385546	CHEMBL4879803	KinomeScan assay: inhibition of MARK3	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5600	Homo sapiens	% Control	%	100.0
